<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN"  "JATS-archivearticle1-3-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic" pub-type="epub">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">104181</article-id><article-id pub-id-type="doi">10.7554/eLife.104181</article-id><article-id pub-id-type="doi" specific-use="version">10.7554/eLife.104181.4</article-id><article-version article-version-type="publication-state">version of record</article-version><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Cell Biology</subject></subj-group></article-categories><title-group><article-title>Forward genetics in <italic>C. elegans</italic> reveals genetic adaptations to polyunsaturated fatty acid deficiency</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Kaper</surname><given-names>Delaney</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-9929-8104</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Radović</surname><given-names>Uroš</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0009-0002-9008-0202</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Bergh</surname><given-names>Per-Olof</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Qvist</surname><given-names>August</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0009-0005-9566-9026</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Henricsson</surname><given-names>Marcus</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Borén</surname><given-names>Jan</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Pilon</surname><given-names>Marc</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-3919-2882</contrib-id><email>marc.pilon@cmb.gu.se</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund2"/><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01tm6cn81</institution-id><institution>Department of Chemistry and Molecular Biology, University of Gothenburg</institution></institution-wrap><addr-line><named-content content-type="city">Gothenburg</named-content></addr-line><country>Sweden</country></aff><aff id="aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01tm6cn81</institution-id><institution>Department of Molecular and Clinical Medicine/Wallenberg Laboratory, Institute of Medicine, University of Gothenburg</institution></institution-wrap><addr-line><named-content content-type="city">Gothenburg</named-content></addr-line><country>Sweden</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Campelo</surname><given-names>Felix</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/03g5ew477</institution-id><institution>Institute of Photonic Sciences</institution></institution-wrap><addr-line><named-content content-type="city">Barcelona</named-content></addr-line><country>Spain</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Campelo</surname><given-names>Felix</given-names></name><role>Senior Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/03g5ew477</institution-id><institution>Institute of Photonic Sciences</institution></institution-wrap><addr-line><named-content content-type="city">Barcelona</named-content></addr-line><country>Spain</country></aff></contrib></contrib-group><pub-date publication-format="electronic" date-type="publication"><day>08</day><month>07</month><year>2025</year></pub-date><volume>13</volume><elocation-id>RP104181</elocation-id><history><date date-type="sent-for-review" iso-8601-date="2024-11-08"><day>08</day><month>11</month><year>2024</year></date></history><pub-history><event><event-desc>This manuscript was published as a preprint.</event-desc><date date-type="preprint" iso-8601-date="2024-11-11"><day>11</day><month>11</month><year>2024</year></date><self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2024.11.08.622646"/></event><event><event-desc>This manuscript was published as a reviewed preprint.</event-desc><date date-type="reviewed-preprint" iso-8601-date="2024-12-20"><day>20</day><month>12</month><year>2024</year></date><self-uri content-type="reviewed-preprint" xlink:href="https://doi.org/10.7554/eLife.104181.1"/></event><event><event-desc>The reviewed preprint was revised.</event-desc><date date-type="reviewed-preprint" iso-8601-date="2025-06-06"><day>06</day><month>06</month><year>2025</year></date><self-uri content-type="reviewed-preprint" xlink:href="https://doi.org/10.7554/eLife.104181.2"/></event><event><event-desc>The reviewed preprint was revised.</event-desc><date date-type="reviewed-preprint" iso-8601-date="2025-06-20"><day>20</day><month>06</month><year>2025</year></date><self-uri content-type="reviewed-preprint" xlink:href="https://doi.org/10.7554/eLife.104181.3"/></event></pub-history><permissions><copyright-statement>© 2024, Kaper et al</copyright-statement><copyright-year>2024</copyright-year><copyright-holder>Kaper et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-104181-v1.pdf"/><self-uri content-type="figures-pdf" xlink:href="elife-104181-figures-v1.pdf"/><related-article related-article-type="commentary" ext-link-type="doi" xlink:href="10.7554/eLife.108249" id="ra1"/><abstract><p>Polyunsaturated fatty acids (PUFAs) are essential for mammalian health and function as membrane fluidizers and precursors for signaling lipids, though the primary essential function of PUFAs within organisms has not been established. Unlike mammals who cannot endogenously synthesize PUFAs, <italic>C. elegans</italic> can de novo synthesize PUFAs starting with the Δ12 desaturase FAT-2, which introduces a second double bond to monounsaturated fatty acids to generate the PUFA linoleic acid. FAT-2 desaturation is essential for <italic>C. elegans</italic> survival since <italic>fat-2</italic> null mutants are non-viable; the near-null <italic>fat-2(wa17</italic>) allele synthesizes only small amounts of PUFAs and produces extremely sick worms. Using fluorescence recovery after photobleaching (FRAP), we found that the <italic>fat-2(wa17</italic>) mutant has rigid membranes and can be efficiently rescued by dietarily providing various PUFAs, but not by fluidizing treatments or mutations. With the aim of identifying mechanisms that compensate for PUFA-deficiency, we performed a forward genetics screen to isolate novel <italic>fat-2(wa17</italic>) suppressors and identified four internal mutations within <italic>fat-2</italic> and six mutations within the HIF-1 pathway. The suppressors increase PUFA levels in <italic>fat-2(wa17</italic>) mutant worms and additionally suppress the activation of the <italic>daf-16</italic>, UPR<sup>er</sup> and UPR<sup>mt</sup> stress response pathways that are active in <italic>fat-2(wa17</italic>) worms. We hypothesize that the six HIF-1 pathway mutations, found in <italic>egl-9</italic>, <italic>ftn-2</italic>, and <italic>hif-1,</italic> all converge on raising Fe<sup>2+</sup> levels and in this way boost desaturase activity, including that of the <italic>fat-2(wa17</italic>) allele. We conclude that PUFAs cannot be genetically replaced and that the only genetic mechanism that can alleviate PUFA-deficiency do so by increasing PUFA levels.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>HIF-1</kwd><kwd>desaturase</kwd><kwd>polyunsaturated fatty acids</kwd><kwd>ferritin</kwd><kwd>forward genetics</kwd><kwd>EGL-9</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd><italic>C. elegans</italic></kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100002794</institution-id><institution>Cancerfonden</institution></institution-wrap></funding-source><award-id>22 1984 Pj</award-id><principal-award-recipient><name><surname>Pilon</surname><given-names>Marc</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100004359</institution-id><institution>Vetenskapsrådet</institution></institution-wrap></funding-source><award-id>2024-04012</award-id><principal-award-recipient><name><surname>Pilon</surname><given-names>Marc</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution>NIH Office of Research Infrastructure Programs</institution></institution-wrap></funding-source><award-id>P40 OD010440</award-id></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Polyunsaturated fatty acids are not genetically replaceable in the nematode <italic>C. elegans</italic> and only mutations that help free ferrous ions can boost the activity of a poorly functioning desaturase enzyme.</meta-value></custom-meta><custom-meta specific-use="meta-only"><meta-name>publishing-route</meta-name><meta-value>prc</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>The fluidity of cellular membranes is heavily influenced by the saturation level of the phospholipids composing the membrane. Phospholipids containing saturated fatty acid (SFA) tails are more tightly packed and, therefore, form more rigid membranes, while phospholipids with an abundance of unsaturated fatty acids (UFAs) are more loosely packed and result in fluid membranes (<xref ref-type="bibr" rid="bib2">Barelli and Antonny, 2016</xref>; <xref ref-type="bibr" rid="bib1">Antonny et al., 2015</xref>). PUFAs themselves can also affect many different cellular processes and are precursors to both anti- and pro-inflammatory PUFA-derived signaling molecules called eicosanoids (<xref ref-type="bibr" rid="bib3">Bazinet and Layé, 2014</xref>; <xref ref-type="bibr" rid="bib73">Simopoulos, 1999</xref>; <xref ref-type="bibr" rid="bib34">James et al., 2000</xref>; <xref ref-type="bibr" rid="bib4">Bell et al., 1986</xref>). Imbalances between SFAs and PUFAs are associated with chronic diseases including coronary heart disease, diabetes, hypertension, and renal disease (<xref ref-type="bibr" rid="bib73">Simopoulos, 1999</xref>).</p><p><italic>C. elegans</italic> PAQR-2, and its mammalian ortholog AdipoR2, promote the production and incorporation of PUFAs into phospholipids to restore membrane homeostasis (<xref ref-type="bibr" rid="bib68">Ruiz et al., 2023</xref>). Whether this is the primary function of PUFAs in cells or in organismal physiology is still not resolved. In particular, no unbiased forward genetic screens for suppressors of PUFA deficiency have been reported. Mammals are not able to endogenously synthesize PUFAs and must obtain omega-3 and omega-6 PUFAs from the diet, a fact known since 1930; <xref ref-type="bibr" rid="bib52">Murff and Edwards, 2014</xref>; <xref ref-type="bibr" rid="bib6">Burr and Burr, 1930</xref>; linoleic acid (LA, 18:2n6) and alpha-linolenic acid (ALA, 18:3n3) must be dietarily supplied and can be further desaturated and elongated into ≥20-carbon PUFAs used structurally or as precursors of signaling molecules (<xref ref-type="bibr" rid="bib85">Watts and Browse, 2002</xref>). An exception to this exists during severe essential fatty acid deficiency when mammals can synthesize mead acid (20:3n9), though this is not a common occurrence (<xref ref-type="bibr" rid="bib33">Ichi et al., 2014</xref>). In contrast, <italic>C. elegans</italic> expresses many desaturases and elongases that can convert dietary or de novo synthesized SFAs into a wide range of PUFAs: Δ9 desaturases are responsible for converting SFAs into monounsaturated fatty acids (MUFAs) by adding a first double bond, a Δ12 desaturase adds an additional double bond to transform MUFAs into LA, a PUFA with two double bonds, and Δ5 and Δ6 desaturases introduce additional double bonds to produce PUFAs with three, four, or five double bonds (<xref ref-type="bibr" rid="bib53">Nakamura and Nara, 2004</xref>; <xref ref-type="bibr" rid="bib25">Guillou et al., 2010</xref>; <xref ref-type="bibr" rid="bib92">Zhang et al., 2016</xref>). To better understand the essential roles of PUFAs in cells and whole organisms, we leveraged a mutant allele of the <italic>C. elegans</italic> Δ12 desaturase FAT-2, whose function is to convert oleic acid (OA, 18:1n9) into linoleic acid (LA, 18:2n6) (<xref ref-type="bibr" rid="bib60">Peyou-Ndi et al., 2000</xref>; <xref ref-type="fig" rid="fig1">Figure 1A</xref>). Because this is a critical step for PUFA production, worms devoid of FAT-2 activity (i.e. <italic>fat-2(-</italic>) null mutants) are not able to synthesize any PUFAs and are not viable. In contrast, the <italic>fat-2(wa17</italic>) allele produces a partially functional protein bearing a S101F substitution (<xref ref-type="fig" rid="fig1">Figure 1B–C</xref>): mutants homozygous for this allele produce &lt;10% of the normal levels of PUFAs and are extremely slow growing and sickly, but, crucially, are viable (<xref ref-type="bibr" rid="bib85">Watts and Browse, 2002</xref>).</p><fig id="fig1" position="float"><label>Figure 1.</label><caption><title><italic>C.</italic><italic>elegans</italic> fatty acid synthesis pathway and FAT-2 desaturase.</title><p>(<bold>A</bold>) Simplified pathway of fatty acid synthesis and desaturation in <italic>C. elegans.</italic> Boxes indicate the name of the enzymes, with the FAT-2 desaturase being indicated in a red box. Fatty acids whose synthesis is dependent on FAT-2 are indicated in red. Fatty acid abbreviations are as follow: palmitic acid (PA), palmitoleic acid (POA), vaccenic acid (VA), stearic acid (SA), oleic acid (OA), linoleic acid (LA), alpha-linolenic acid (ALA), gamma-linolenic acid (GLA), stearidonic acid (STA), dihomo-gamma-linolenic acid (DGLA), eicosatetraenoic acid (ETA), arachidonic acid (AA), and eicosapentaenoic acid (EPA). (<bold>B</bold>) AlphaFold2 predicted the FAT-2 structure with the serine at position 101 indicated with a red arrow. (<bold>C</bold>) Same structure as in B, zoomed in and angled to show that the S101 position that is mutated to phenylalanine in the <italic>fat-2(wa17)</italic> allele lies in a loop connecting two alpha helices.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-104181-fig1-v1.tif"/></fig><p>Although there is no mammalian homolog of FAT-2 (<xref ref-type="bibr" rid="bib93">Zhou et al., 2011</xref>), the <italic>fat-2(wa17)</italic> mutant can still serve as a useful genetic model to reveal evolutionarily conserved roles of PUFAs in organisms, and to help identify mechanisms that can compensate for PUFA deficiency. Here, we began by characterizing the <italic>fat-2(wa17)</italic> mutant in terms of its ability to be rescued with dietary PUFAs or with mutations previously identified as suppressors of <italic>paqr-2(tm3410)</italic> mutant phenotypes that are attributed to membrane rigidity. We then performed an exhaustive forward genetic screen for <italic>fat-2(wa17)</italic> suppressors in the hope that the critical functions of PUFAs could be discovered and to identify mechanisms that allow cells/organisms to cope with PUFA deficiencies. This screen yielded ten <italic>fat-2(wa17)</italic> suppressor alleles that fell into two groups: mutations within <italic>fat-2</italic> itself, and mutations in the <italic>hif-1</italic> pathway that converge on inhibition of <italic>ftn-2</italic> expression.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>Characterization of the <italic>fat-2(wa17)</italic> mutant</title><p>The severe growth defect of <italic>fat-2(wa17</italic>) mutants can be suppressed by the wild-type <italic>fat-2(+)</italic> allele carried on an extrachromosomal array, confirming that this growth defect is due to reduced <italic>fat-2</italic> activity (<xref ref-type="fig" rid="fig2">Figure 2A</xref>). As expected, given their low amounts of PUFAs, fluorescence recovery after photobleaching (FRAP) shows that the membranes of intestinal cells in the <italic>fat-2(wa17)</italic> mutant are excessively rigid and indeed appeared as rigid as those of the <italic>paqr-2(tm3410)</italic> mutant characterized by an excess of SFAs in its phospholipids (<xref ref-type="bibr" rid="bib77">Svensk et al., 2013</xref>; <xref ref-type="bibr" rid="bib78">Svensk et al., 2016</xref>; <xref ref-type="fig" rid="fig2">Figure 2B–C</xref>).</p><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>Characterization and rescue of <italic>fat-2(wa17).</italic></title><p>(<bold>A</bold>) Introduction of the wild-type <italic>fat-2(+)</italic> allele on an extrachromosomal array rescues the <italic>fat-2(wa17)</italic> growth defect. n=20 for each genotype. (<bold>B</bold>–<bold>C</bold>) Fluorescence recovery after photobleaching (FRAP) curve and T<sub>half</sub> value show that <italic>fat-2(wa17)</italic> has rigid membranes similar to <italic>paqr-2(tm3410)</italic> control. n=8 for each genotype. (<bold>D</bold>–<bold>I</bold>, <bold>K</bold>–<bold>M</bold>) The lengths of <italic>fat-2(wa17)</italic> worms grown from L1 stage for 72 hr in the indicated conditions; horizontal dashed lines indicate the approximate lengths of the synchronized L1s at the start of the experiments. n=20 for each genotype/condition. (<bold>J</bold>) FRAP T<sub>half</sub> values show that NP-40 rescues <italic>fat-2(wa17)</italic> rigid membranes similarly to <italic>paqr-2(tm3410).</italic> From left to right, n=6, 8, 7, 7, 8. Error bars show the standard error of the mean. *p&lt;0.05, **p&lt;0.01, ***p&lt;0.001 indicate significant differences compared to the <italic>fat-2(wa17)</italic> control (ordinary one-way ANOVA with Tukey multiple comparisons test).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-104181-fig2-v1.tif"/></fig><p>Also, as expected, low doses of dietary linoleic acid (LA, 18:2n6) fully rescued the <italic>fat-2(wa17)</italic> growth defect (<xref ref-type="fig" rid="fig2">Figure 2D</xref>). This rescue by LA is transient and does not last when the following generation is transferred back to NGM plates (<xref ref-type="fig" rid="fig2">Figure 2E</xref>), which is consistent with the rapid turnover of fatty acids in <italic>C. elegans</italic> (<xref ref-type="bibr" rid="bib15">Dancy et al., 2015</xref>). Eicosapentaenoic acid (EPA, 20:5n3) is the longest and most unsaturated PUFA produced in <italic>C. elegans</italic> (<xref ref-type="fig" rid="fig1">Figure 1A</xref>) and is also able to rescue the <italic>fat-2(wa17)</italic> mutant, albeit requiring higher concentrations than LA (<xref ref-type="fig" rid="fig2">Figure 2F</xref>). Surprisingly, docosahexaenoic acid (DHA, 22:6n3), which is not produced by <italic>C. elegans</italic>, is also able to rescue the <italic>fat-2(wa17)</italic> mutant (<xref ref-type="fig" rid="fig2">Figure 2G</xref>). Temperature has a direct effect on membrane fluidity: given a constant phospholipid composition, lower temperatures cause rigidification while higher temperatures promote fluidity (<xref ref-type="bibr" rid="bib79">Tanaka et al., 1996</xref>). We found that the <italic>fat-2(wa17)</italic> mutant is growth-arrested when cultivated at membrane-rigidifying 15 °C, and conversely shows improved growth at 25 °C, which again is similar to earlier findings with the <italic>paqr-2(tm3410)</italic> mutant (<xref ref-type="bibr" rid="bib19">Devkota et al., 2021</xref>; <xref ref-type="fig" rid="fig2">Figure 2H</xref>). However, cultivating the <italic>fat-2(wa17)</italic> mutant in the presence of the non-ionic detergent NP-40, which improves the growth of the <italic>paqr-2(tm3410)</italic> mutant (<xref ref-type="bibr" rid="bib77">Svensk et al., 2013</xref>), did not suppress the poor growth phenotype of the <italic>fat-2(wa17)</italic> mutant even though it did improve membrane fluidity as measured using FRAP (<xref ref-type="fig" rid="fig2">Figure 2I–J</xref>). Similarly, supplementing the <italic>fat-2(wa17)</italic> mutant with the MUFA oleic acid (OA, 18:1), which also suppresses <italic>paqr-2(tm3410)</italic> phenotypes (<xref ref-type="bibr" rid="bib77">Svensk et al., 2013</xref>), did not suppress the poor growth phenotype of the <italic>fat-2(wa17)</italic> mutant (<xref ref-type="fig" rid="fig2">Figure 2K</xref>). Conversely, membrane-rigidifying glucose (which causes a high SFA/UFA ratio in the dietary <italic>E. coli</italic>; <xref ref-type="bibr" rid="bib17">Devkota et al., 2017</xref>) or the SFA palmitic acid (PA, 16:0) did not exacerbate the growth defect of <italic>fat-2(wa17)</italic> (<xref ref-type="fig" rid="fig2">Figure 2L–M</xref>). The observations that NP-40 and OA do not rescue <italic>fat-2(wa17)</italic>, and that membrane rigidifying conditions (dietary glucose or PA) were not detrimental to <italic>fat-2(wa17),</italic> suggest that membrane rigidification may not be the main cause of the <italic>fat-2(wa17)</italic> growth defects.</p><p>Lipidomic analysis of phosphatidylcholines (PCs) and phosphatidylethanolamines (PEs) in the <italic>fat-2(wa17)</italic> mutant confirmed its reduced levels of PUFAs relative to wild-type worms (<xref ref-type="fig" rid="fig3">Figure 3A</xref>; <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1A</xref>), with the largest loss observed in longer PUFAs, namely dihomo-γ-linolenic acid (DGLA; C20:3), arachidonic acid or eicosatetraenoic acid (AA or ETA, C20:4) and, most strikingly, EPA (C20:5) (<xref ref-type="fig" rid="fig3">Figure 3B–C</xref>; <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1B–C</xref>). Consistent with previous publications (<xref ref-type="bibr" rid="bib85">Watts and Browse, 2002</xref>), the levels of 18:1 fatty acids were greatly increased in the <italic>fat-2(wa17)</italic> mutant. Even though the lipid analysis methods used here are not able to distinguish between different 18:1 species, a previous study showed that the majority of the 18:1 fatty acids in the <italic>fat-2(wa17)</italic> mutant is actually 18:1n9 (OA) (<xref ref-type="bibr" rid="bib85">Watts and Browse, 2002</xref>) and not 18:1n7 (vaccenic acid) as in most other strains (<xref ref-type="bibr" rid="bib85">Watts and Browse, 2002</xref>; <xref ref-type="bibr" rid="bib31">Hutzell and Krusberg, 1982</xref>); this is because OA is the substrate of FAT-2 and thus accumulates in the mutant. As expected, exogenous addition of LA to these worms resulted in an increase of PUFAs, and in particular, resulted in elevating EPA levels to more than 12% compared to less than 2% of total fatty acids in the PCs of <italic>fat-2(wa17)</italic>. Transferring <italic>fat-2(wa17)</italic> from LA to NGM 6 hr prior to harvesting did not lessen this increase, suggesting minimal LA depletion during this time (<xref ref-type="fig" rid="fig3">Figure 3A–C</xref>; <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1A–C</xref>). Cultivation at 25°C did not result in any significant changes in the <italic>fat-2(wa17)</italic> mutant, indicating that the growth rescue seen at 25°C is not due to increased PUFA levels in the lipidome (<xref ref-type="fig" rid="fig3">Figure 3A–C</xref>; <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1A–C</xref>).</p><fig-group><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>Lipidomic analysis of <italic>fat-2(wa17)</italic> mutant.</title><p>(<bold>A</bold>) Saturated fatty acid (SFA), monounsaturated fatty acid (MUFA), and polyunsaturated fatty acid (PUFA) levels in phosphatidylcholines (PCs) of <italic>fat-2(wa17)</italic> grown in various conditions. Note that cultivation on 2 mM LA boosts PUFA levels. Linoleic acid (LA) to NGM worms were grown on 2 mM LA before being transferred to NGM 6 hr prior to harvesting. (<bold>B</bold>) Heatmap of phosphatidylcholine (PC) species in <italic>fat-2(wa17)</italic> in all conditions. (<bold>C</bold>) Levels of individual FA species in PCs for all conditions. The inset shows that levels of 20:5 FA are increased by providing <italic>fat-2(wa17</italic>) with linoleic acid. n=4 populations for each genotype/condition. For A and C (inset), *p&lt;0.05, **p&lt;0.01, ***p&lt;0.001 indicate significant differences compared to the <italic>fat-2(wa17)</italic> control and using one-way ANOVA followed by a Dunnett’s multiple comparison test.</p><p><supplementary-material id="fig3sdata1"><label>Figure 3—source data 1.</label><caption><title>Data from the targeted lipidomics analysis, related to <xref ref-type="fig" rid="fig3">Figures 3</xref> and <xref ref-type="fig" rid="fig7">7</xref>, <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>, <xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-104181-fig3-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-104181-fig3-v1.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 1.</label><caption><title>Lipidomics analysis of phosphatidylethanolamines (PEs) in <italic>fat-2(wa17)</italic> in various cultivation conditions.</title><p>(<bold>A</bold>) Saturated fatty acid (SFA), monounsaturated fatty acid (MUFA), and polyunsaturated fatty acid (PUFA) levels in phosphatidylethanolamine (PEs) of <italic>fat-2(wa17)</italic> grown in various conditions. Cultivation on 2 mM linoleic acid (LA) boosts PUFA levels. LA to NGM worms were grown on 2 mM LA before being transferred to NGM 6 hr prior to harvesting. (<bold>B</bold>) Heatmap of PE species in <italic>fat-2(wa17)</italic> in all conditions. (<bold>C</bold>) Levels of individual FA species in PEs for all conditions. Inset shows that the levels of C20:5 are increased by providing <italic>fat-2(wa17)</italic> with LA. n=4 populations for each genotype/condition. For A and C (inset), *p&lt;0.05, **p&lt;0.01, ***p&lt;0.001 indicate significant differences compared to the <italic>fat-2(wa17)</italic> control and using one-way ANOVA followed by a Dunnett’s multiple comparison test.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-104181-fig3-figsupp1-v1.tif"/></fig></fig-group></sec><sec id="s2-2"><title>Testing the effect of <italic>paqr-2(tm3410)</italic> suppressors</title><p>The previously characterized <italic>paqr-2(tm3410)</italic> null mutant has excess SFAs within phospholipids and many of the resulting defects, including membrane rigidity, can be suppressed by mutations that activate fatty acid desaturases or promote the incorporation of UFAs into phospholipids (<xref ref-type="bibr" rid="bib77">Svensk et al., 2013</xref>; <xref ref-type="bibr" rid="bib66">Ruiz et al., 2018</xref>; <xref ref-type="bibr" rid="bib67">Ruiz et al., 2019</xref>; <xref ref-type="bibr" rid="bib7">Busayavalasa et al., 2020</xref>). Given the phenotypic similarities between <italic>paqr-2(tm3410)</italic> and <italic>fat-2(wa17)</italic>, such as cold intolerance and rigid membranes, we hypothesized that previously characterized <italic>paqr-2(tm3410)</italic> suppressors may be able to suppress <italic>fat-2(wa17)</italic> as well. However, the <italic>paqr-2(tm3410)</italic> suppressors tested (<italic>mdt-15(et14), nhr-49(et8), fld-1(et46), paqr-1(et52), acs-13(et54)</italic>; <xref ref-type="bibr" rid="bib77">Svensk et al., 2013</xref>; <xref ref-type="bibr" rid="bib66">Ruiz et al., 2018</xref>; <xref ref-type="bibr" rid="bib67">Ruiz et al., 2019</xref>; <xref ref-type="bibr" rid="bib7">Busayavalasa et al., 2020</xref>) resulted in either no or only slight rescue of <italic>fat-2(wa17)</italic> growth (<xref ref-type="fig" rid="fig4">Figure 4A–D</xref>). Additionally, Oil Red O staining of <italic>fat-2(wa17)</italic> mutants suggests that they have an excessive lipid content, and this too was not normalized by the tested <italic>paqr-2(tm3410)</italic> suppressors (<xref ref-type="fig" rid="fig4">Figure 4E–G</xref>). These results suggest that membrane rigidity is at most only a minor cause of the <italic>fat-2(wa17)</italic> defects since fluidizing treatments (NP-40 or OA) or mutations (the tested <italic>paqr-2</italic> suppressors) provide only minimal or no suppression.</p><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>Membrane fluidizing mutations partially rescue <italic>fat-2(wa17).</italic></title><p>(<bold>A</bold>–<bold>D</bold>) Fluidizing <italic>paqr-2(tm3410)</italic> suppressor mutations only slightly rescue <italic>fat-2(wa17)</italic> growth. Dashed horizontal lines indicate the approximate length of L1s at the start of the experiments; length was measured 72 hr post-synchronization. n=20 for each genotype. Error bars show the standard error of the mean. *p&lt;0.05, **p&lt;0.01, ***p&lt;0.001 indicate significant differences compared to the <italic>fat-2(wa17)</italic> control (ordinary one-way ANOVA with Tukey multiple comparisons test). (<bold>E–G</bold>) Oil Red O staining of day 1 adults shows that the high lipid abundance in <italic>fat-2(wa17)</italic> is not suppressed by <italic>paqr-2(tm3410)</italic> fluidizing mutations.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-104181-fig4-v1.tif"/></fig></sec><sec id="s2-3"><title>A forward genetics screen for <italic>fat-2(wa17)</italic> suppressors</title><p>With the aim of identifying essential roles of PUFAs and molecular mechanisms that can compensate for PUFA deficiency, we performed a forward genetic screen for <italic>fat-2(wa17)</italic> suppressors that allow growth to adulthood within 72 hr, as opposed to the ~120 hr needed for the parental strain (<xref ref-type="fig" rid="fig5">Figure 5A</xref>). Approximately 40,000 EMS-mutagenized haploid genomes were screened, leading to the isolation of ten <italic>fat-2(wa17)</italic> suppressors, which fell into two groups: mutations within the <italic>fat-2</italic> locus itself and mutations within genes of the HIF-1 pathway (<xref ref-type="fig" rid="fig5">Figure 5B–C</xref>). The <italic>fat-2(wa17)</italic> suppressors all reached adulthood within 72 hr (criteria for the screen) and improved the growth of the mutant when assessed by measuring worm length at 72 hr (<xref ref-type="fig" rid="fig5">Figure 5D–E</xref>). The <italic>hif-1(et69)</italic> mutation was recreated by CRISPR-Cas9 within the <italic>fat-2(wa17)</italic> background to confirm its <italic>fat-2(wa17)</italic> suppressor activity (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1A</xref>); multiple independent isolations of essentially the same alleles within <italic>egl-9</italic> (alelles <italic>et60-et62)</italic>, <italic>fat-2 (</italic>alleles <italic>et63-et66), and ftn-2(et67-68)</italic> also serve as confirmation for these loci.</p><fig-group><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>A forward genetic screen reveals that <italic>fat-2(wa17)</italic> is suppressed by mutations in the HIF-1 pathway.</title><p>(<bold>A</bold>) Overview of the forward genetics screen strategy to isolate <italic>fat-2(wa17)</italic> suppressors. (<bold>B</bold>) Identity and position of the <italic>fat-2(wa17)</italic> suppressors as well as the positions of functional domains. Novel mutations are marked by a black triangle with the corresponding allele name and mutation effect; the red triangle in FAT-2 indicates the original <italic>wa17</italic> allele. Gene names in red represent loss- or reduction-of-function mutations; gene names in green represent gain-of-function mutations. (<bold>C</bold>) Proposed pathway of <italic>fat-2(wa17)</italic> suppression by mutations in the HIF-1 pathway. Reduction of EGL-9 constitutively activates HIF-1, and HIF-1 activation inhibits FTN-2. The loss of FTN-2 increases the levels of Fe<sup>2+</sup>, thus boosting FAT-2 desaturase activity. Gain-of-function mutations are labeled in green, loss- or reduction-of-function mutations are labeled in red. (<bold>D</bold>) Length of all <italic>fat-2(wa17)</italic> suppressors measured 72 hr after the L1 stage. (<bold>E</bold>) Representative images of <italic>fat-2(wa17)</italic> suppressors after 72 h of growth. (<bold>F</bold>–<bold>H</bold>) Null alleles of <italic>egl-9</italic> and <italic>hif-1</italic> do not rescue <italic>fat-2(wa17)</italic>, but the null allele of <italic>ftn-2</italic> does, confirming that <italic>ftn-2(et67)</italic> and <italic>ftn-2(et68</italic>) are loss-of-function alleles. Lengths were measured 72 hr after L1 synchronization. (<bold>I</bold>) <italic>ftn-2(et68)</italic> rescue of <italic>fat-2(RNAi)</italic> worms, confirming that the suppressors are not <italic>wa17</italic> specific. The horizontal dashed line indicates the approximate length of L1s at the start of each experiment. n=20 for each genotype/condition. Error bars show the standard error of the mean. *p&lt;0.05, **p&lt;0.01, ***p&lt;0.001 indicate significant differences compared to the <italic>fat-2(wa17)</italic> control (ordinary one-way ANOVA with Tukey multiple comparisons test).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-104181-fig5-v1.tif"/></fig><fig id="fig5s1" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 1.</label><caption><title><italic>fat-2(wa17)</italic> and <italic>fat-2(syb7458)</italic> with suppressors.</title><p>(<bold>A</bold>) Confirmation of <italic>hif-1(et69)</italic> suppression of <italic>fat-2(wa17</italic>) by CRISPR-Cas9. (<bold>B</bold>) The <italic>hif-1(et69)</italic> allele acts best as a <italic>fat-2(wa17)</italic> suppressor when in a heterozygous state. (<bold>C</bold>) <italic>ftn-2(et68)</italic> does not act as a suppressor for the <italic>fat-2(syb7458)</italic> allele. (<bold>D</bold>) <italic>ftn-2(et68)</italic> still suppresses <italic>fat-2(wa17)</italic> in a <italic>hif-1</italic> null background. (<bold>E</bold>) <italic>hif-1(et69)</italic> suppresses <italic>fat-2(wa17)</italic> in a <italic>ftn-2</italic> null background. (<bold>A–E</bold>) All length measurements were taken 72 hr after L1 synchronization. The horizontal dashed line represents the approximate size of L1s at the start of each experiment. n=20 for each genotype/conditions. Error bars show the standard error of the mean. *p&lt;0.05, **p&lt;0.01, ***p&lt;0.001 indicate significant differences compared to the <italic>fat-2(wa17)</italic> control (ordinary one-way ANOVA with Tukey multiple comparisons test).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-104181-fig5-figsupp1-v1.tif"/></fig></fig-group><p>Three of the four <italic>fat-2</italic> intragenic alleles (<italic>et64-et66</italic>) carried a substitution of serine to leucine at position 99 (S99L), only two amino acids away from the S101F mutation in <italic>fat-2(wa17)</italic>; the fourth, <italic>et63</italic>, is a missense mutation substituting valine with methionine at position 25 (V25M; <xref ref-type="fig" rid="fig5">Figure 5B</xref>). These four internal <italic>fat-2</italic> alleles likely compensate structurally for the S101F mutation in <italic>fat-2(wa17)</italic> and thus improve its activity.</p><p>Three independent <italic>fat-2(wa17)</italic> suppressor mutations were found to affect the same arginine at position 557 of EGL-9 (<italic>et60 and et61</italic> resulted in a R557H missense while <italic>et62</italic> caused a R557C missense; <xref ref-type="fig" rid="fig5">Figure 5B</xref>). EGL-9 is a proline hydroxylase (PHD) that interacts via its R557 with Fe<sup>2+</sup>/2-oxoglutarate, a required cofactor for its oxygenase activity (<xref ref-type="bibr" rid="bib23">Epstein et al., 2001</xref>). EGL-9 regulates the response to iron depletion and hypoxia: in the presence of sufficient Fe<sup>2+</sup> and oxygen, EGL-9 can hydroxylate HIF-1 (hypoxia-inducible factor 1), leading to its ubiquitination and degradation. When either Fe<sup>2+</sup> or oxygen are unavailable, HIF-1 is stable and can bind DNA to regulate adaptive transcriptional responses (<xref ref-type="bibr" rid="bib23">Epstein et al., 2001</xref>; <xref ref-type="bibr" rid="bib5">Bracken et al., 2006</xref>; <xref ref-type="bibr" rid="bib29">Huang et al., 1996</xref>). It is surprising that all three <italic>fat-2(wa17)</italic> suppressor alleles affected precisely the same amino acid within EGL-9, and we surmise that a special property is conferred to EGL-9 by this specific mutation. For example, this mutant version of EGL-9 may be unable to inactivate HIF-1 by hydroxylation but still retain other important functions. In agreement with this interpretation, we found that the <italic>egl-9(sa307)</italic> null mutant cannot act as a <italic>fat-2(wa17)</italic> suppressor (<xref ref-type="fig" rid="fig5">Figure 5F</xref>).</p><p>One of the <italic>fat-2(wa17)</italic> suppressors corresponds to a splice acceptor mutation in the fifth intron of HIF-1, which would result in a frameshift after the first 413 amino acids if splicing instead occurs with the following sixth intron splice acceptor site (<xref ref-type="fig" rid="fig5">Figure 5B</xref>). This <italic>hif-1(et69)</italic> allele is dominant: heterozygosity for <italic>hif-1(et69)/+</italic> provides better <italic>fat-2(wa17)</italic> suppression than <italic>hif-1(et69)/hif-1(et69)</italic> homozygosity (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1B</xref>). This suggests that the <italic>hif-1(et69)</italic> allele is a gain-of-function allele, which may be because the frameshift occurs just after the first of potentially two prolines that are hydroxylated by EGL-9 when oxygen and Fe<sup>2+</sup> levels are sufficient (<xref ref-type="bibr" rid="bib23">Epstein et al., 2001</xref>). This is also consistent with the observation that the <italic>hif-1(ok2654)</italic> null allele is not a <italic>fat-2(wa17)</italic> suppressor (<xref ref-type="fig" rid="fig5">Figure 5G</xref>). Usually, hydroxylation of the prolines P400 and P621 causes recruitment of a ubiquitin ligase, leading to HIF-1 degradation (<xref ref-type="bibr" rid="bib23">Epstein et al., 2001</xref>). In the case of the <italic>hif-1(et69)</italic> allele, such regulation is likely impossible, and a constitutive HIF-1 may act as a <italic>fat-2(wa17)</italic> suppressor in several ways: promote overexpression of lipid metabolism genes including <italic>fat-2</italic> (<xref ref-type="bibr" rid="bib88">Xie and Roy, 2012</xref>), inhibit fatty acid beta-oxidation (<xref ref-type="bibr" rid="bib30">Huang et al., 2014</xref>; <xref ref-type="bibr" rid="bib56">Papandreou et al., 2006</xref>), which may help PUFAs to reach adequate levels even in the <italic>fat-2(wa17)</italic> mutant, or suppress the expression of the ferritin-encoding <italic>ftn-2</italic>, thus increasing the levels of ferrous ions required for desaturase activity (<xref ref-type="bibr" rid="bib65">Romney et al., 2011</xref>; <xref ref-type="bibr" rid="bib71">Shen et al., 2023</xref>).</p><p>Most informatively, the last two <italic>fat-2(wa17)</italic> suppressor mutations introduced premature STOP codons within the <italic>ftn-2</italic> gene (alleles <italic>et67</italic> and <italic>et68</italic>; <xref ref-type="fig" rid="fig5">Figure 5B</xref>). Additionally, the <italic>ftn-2(ok404)</italic> null allele also acted as a potent <italic>fat-2(wa17)</italic> suppressor (<xref ref-type="fig" rid="fig5">Figure 5H</xref>), which is consistent with inhibition of <italic>ftn-2</italic> being the key outcome from HIF-1 pathway activation. <italic>C. elegans ftn-2</italic> encodes a ferritin that is expressed in the intestine, muscle and several neurons (<xref ref-type="bibr" rid="bib64">Romney et al., 2008</xref>). The FTN-2 protein is constitutive and 10 X faster as a ferroxidase (oxidising the reactive ferrous Fe<sup>2+</sup> to the harmless ferric Fe<sup>3+</sup>) than FTN-1, which is an inducible intestine-specific ferritin in <italic>C. elegans</italic> (<xref ref-type="bibr" rid="bib65">Romney et al., 2011</xref>; <xref ref-type="bibr" rid="bib40">Kim et al., 2004</xref>; <xref ref-type="bibr" rid="bib63">Romero et al., 2020</xref>; <xref ref-type="bibr" rid="bib51">Mubarak et al., 2023</xref>; <xref ref-type="bibr" rid="bib11">Cha’on et al., 2007</xref>). Additionally, FTN-2 is the major binder of iron in worms, and <italic>ftn-2</italic> mutants, therefore, contain much less iron than wild-type worms, though the Fe<sup>2+</sup>/Fe<sup>3+</sup> ratio is increased among the remaining iron (<xref ref-type="bibr" rid="bib35">James et al., 2015</xref>). This is likely the mechanism by which the <italic>ftn-2(et67)</italic> and <italic>ftn-2(et68)</italic> alleles act as <italic>fat-2(wa17)</italic> suppressors: increasing the availability of ferrous ions is a potent way to activate desaturases (<xref ref-type="bibr" rid="bib71">Shen et al., 2023</xref>) and thus likely increases the activity of the near null <italic>fat-2(wa17)</italic> allele leading to the production of more/sufficient PUFAs. Importantly, the <italic>ftn-2(et68)</italic> allele was also able to suppress the growth defect resulting from <italic>fat-2</italic> knockdown (using RNAi; <xref ref-type="fig" rid="fig5">Figure 5I</xref>); this shows that ferritin mutations compensate for reduced <italic>fat-2</italic> activity generally rather than suppressing specifically only the <italic>fat-2(wa17)</italic> allele. Additionally, the <italic>ftn-2(et68)</italic> allele was not able to rescue the <italic>fat-2(syb7458)</italic> null allele (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1C</xref>), suggesting that some <italic>fat-2</italic> activity must exist for <italic>ftn-2(et68)</italic> to act upon. Lastly, <italic>ftn-2(et68)</italic> is still a potent <italic>fat-2(wa17)</italic> suppressor when <italic>hif-1</italic> is knocked out (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1D</xref>), suggesting that no other HIF-1-dependent functions are required as long as <italic>ftn-</italic>2 is downregulated; this conclusion is supported by the observation that the potency of the <italic>ftn-2(ok404)</italic> null allele to act as a <italic>fat-2(wa17)</italic> suppressor is not increased by including the <italic>hif-1(et69)</italic> allele (compare <xref ref-type="fig" rid="fig5">Figure 5H</xref> and <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1E</xref>). Altogether, the genetic interaction studies suggest that the suppressor mutations in <italic>ftn-2</italic> and <italic>hif-1</italic> are acting via the same mechanism to rescue <italic>fat-2(wa17)</italic> and that <italic>ftn-2</italic> is downstream of <italic>hif-1</italic> in the <italic>fat-2</italic> suppression pathway.</p></sec><sec id="s2-4"><title>Effect of <italic>fat-2(wa17)</italic> suppressors on HIF-1 and PUFA levels</title><p>The results of the <italic>fat-2(wa17)</italic> suppressor screen support a model where the <italic>egl-9</italic> R557 substitution alleles have an impaired ability to suppress HIF-1, while the gain-of-function <italic>hif-1(et69)</italic> allele constitutively suppresses <italic>ftn-2</italic> expression and the <italic>ftn-2</italic> null alleles are unable to sequester ferrous ions of which elevated levels increase <italic>fat-2</italic> activity (<xref ref-type="fig" rid="fig5">Figure 5C</xref>). A 3xFLAG-tagged version of the endogenous HIF-1 allowed us to monitor HIF-1 levels in different conditions using Western blots (<xref ref-type="fig" rid="fig6">Figure 6A–B</xref>). As expected, hypoxia caused elevated levels of HIF-1 in wild-type worms. HIF-1 levels are abnormally low in <italic>fat-2(wa17)</italic> during normoxia but restored to normal levels by the internal <italic>fat-2(et65)</italic> mutation, suggesting that low PUFA levels cause HIF-1 downregulation. Nevertheless, HIF-1 levels are also increased by hypoxia in the <italic>fat-2(wa17)</italic> mutant, indicating that the <italic>hif-1</italic> locus is still responsive to oxygen levels in the <italic>fat-2(wa17)</italic> mutant. As expected, <italic>egl-9(et60)</italic> drastically increases HIF-1 expression in <italic>fat-2(wa17)</italic>, which is consistent with the R557 substitution impairing the ability of EGL-9 to inhibit HIF-1. Finally, the null <italic>ftn-2(et68)</italic> allele caused near-loss (a faint HIF-1 band is occasionally seen) of detectable HIF-1 in <italic>fat-2(wa17)</italic>, suggesting feedback regulation between <italic>ftn-2</italic> and <italic>hif-1</italic> (<xref ref-type="fig" rid="fig6">Figure 6A–B</xref>, <xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1A–B</xref>).</p><fig-group><fig id="fig6" position="float"><label>Figure 6.</label><caption><title><italic>fat-2(wa17)</italic> suppressors belong in the HIF-1 pathway and influence HIF-1 levels.</title><p>(<bold>A</bold>) Western blot confirming that <italic>hif-1::3xFLAG</italic> levels in <italic>fat-2(wa17</italic>) are increased by <italic>egl-9(et60),</italic> but not by <italic>ftn-2(et68)</italic>. Hypoxia treatment increases HIF-1 levels in wild-type (WT) and <italic>fat-2(wa17)</italic>, confirming successful protein tagging. (<bold>B</bold>) Quantification of Western blot in <bold>A</bold> showing relative intensity of the HIF-1 signal normalized to that of tubulin. (<bold>C</bold>) mRNA expression of FTN-2, confirming that <italic>hif-1(et69)</italic> reduces FTN-2 levels. n = the mean of 3 independent normalized replicates for each genotype. *p&lt;0.05 (unpaired t-test). (<bold>D</bold>) Western blot confirming that <italic>fat-2::HA</italic> levels <italic>in fat-2(wa17)</italic> are greatly reduced but increased in suppressor strains. (<bold>E</bold>) Quantification of Western blot in D showing relative intensity of the FAT-2 signal normalized to that of tubulin.</p><p><supplementary-material id="fig6sdata1"><label>Figure 6—source data 1.</label><caption><title>PDF file containing original western blots for <xref ref-type="fig" rid="fig6">Figure 6</xref>, indicating the relevant bands and treatments.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-104181-fig6-data1-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig6sdata2"><label>Figure 6—source data 2.</label><caption><title>Original files for western blot analysis displayed in <xref ref-type="fig" rid="fig6">Figure 6</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-104181-fig6-data2-v1.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-104181-fig6-v1.tif"/></fig><fig id="fig6s1" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 1.</label><caption><title>Suppressors influence HIF-1 and FAT-2 levels.</title><p>(<bold>A</bold>) Western blot showing that <italic>hif-1::3xFLAG</italic> levels in <italic>fat-2(wa17)</italic> are increased by <italic>egl-9(et60)</italic>. (<bold>B</bold>) Quantification of Western blot in A showing normalized relative intensity of the HIF-1 signal to that of tubulin. (<bold>C</bold>) Western blot showing that <italic>fat-2::HA</italic> levels are reduced in <italic>fat-2(wa17)</italic> but increased by suppressors. (<bold>D</bold>) Quantification of Western blot in C showing normalized relative intensity of HIF-1 signal to that of tubulin.</p><p><supplementary-material id="fig6s1sdata1"><label>Figure 6—figure supplement 1—source data 1.</label><caption><title>PDF file containing original western blots for <xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1</xref>, indicating the relevant bands and treatments.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-104181-fig6-figsupp1-data1-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig6s1sdata2"><label>Figure 6—figure supplement 1—source data 2.</label><caption><title>Original files for western blot analysis displayed in <xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-104181-fig6-figsupp1-data2-v1.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-104181-fig6-figsupp1-v1.tif"/></fig></fig-group><p>Inhibition of <italic>egl-9</italic> promotes HIF-1 activity (<xref ref-type="bibr" rid="bib69">Shao et al., 2009</xref>), which we here verified for <italic>the egl-9(et60</italic>) allele using western blots (<xref ref-type="fig" rid="fig6">Figure 6A</xref>). Additionally, we found by qPCR that <italic>ftn-2</italic> mRNA levels are as expected reduced by the proposed gain-of-function <italic>hif-1(et69)</italic> allele (<xref ref-type="fig" rid="fig6">Figure 6C</xref>). We conclude that the <italic>egl-9</italic> and <italic>hif-1</italic> suppressor mutations likely converge on inhibiting <italic>ftn-2</italic> and thus act similarly to the <italic>ftn-2</italic> loss-of-function alleles.</p><p>We also used Western blots to evaluate the abundance of the FAT-2 protein expressed from endogenous wild-type or mutant loci, but to which a HA tag was fused using CRISPR/Cas9. We found that the FAT-2::HA levels are severely reduced when the locus contains the S101F substitution present in the <italic>wa17</italic> allele, but are restored close to wild-type levels by the <italic>fat-2(et65)</italic> suppressor mutation (<xref ref-type="fig" rid="fig6">Figure 6D–E</xref>, <xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1C–D</xref>). The levels of FAT-2 in the HIF-1 pathway suppressors varied between experiments, with the suppressors sometimes restoring FAT-2 levels and sometimes not, even when the worms were growing well (<xref ref-type="fig" rid="fig6">Figure 6D–E</xref>, <xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1C–D</xref>). The <italic>fat-2(wa17)</italic> suppressors, except for the intragenic <italic>fat-2</italic> alleles, likely do not act by increasing FAT-2 protein levels.</p><p>As already mentioned, ferrous ions (Fe<sup>2+</sup>) are potent activators of desaturases (<xref ref-type="bibr" rid="bib71">Shen et al., 2023</xref>). Given that each of the <italic>fat-2(wa17)</italic> suppressor mutants within the HIF-1 pathway are predicted to ultimately inhibit <italic>ftn-2</italic>, thus increasing the ferrous ion pool, we hypothesized that PUFA levels should be at least partially normalized in the <italic>fat-2(wa17)</italic> suppressors. This was confirmed by lipidomic analysis of phosphatidylcholines (<xref ref-type="fig" rid="fig7">Figure 7A</xref>) and phosphatidylethanolamines (<xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1A</xref>). In particular, while levels of 18:2 (LA) were not significantly increased in the suppressor strains, the levels of 20:5 (EPA) were significantly increased by more than three folds and to levels near those obtained earlier by supplementing with LA (<xref ref-type="fig" rid="fig7">Figure 7B–C</xref>, <xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1B–C</xref>), likely because the suppressor mutations allow <italic>fat-2(wa17)</italic> to produce more LA that is converted by other elongases and desaturases into EPA, the end product.</p><fig-group><fig id="fig7" position="float"><label>Figure 7.</label><caption><title>Lipidomic analysis of <italic>fat-2(wa17)</italic> suppressors reveals that polyunsaturated fatty acid (PUFA) levels are increased.</title><p>(<bold>A</bold>) Levels of saturated fatty acids (SFAs), monounsaturated fatty acids (MUFAs), and PUFAs in phosphatidylcholines (PCs) measured in <italic>fat-2(wa17)</italic> suppressors confirm that the suppressors increase PUFA levels in <italic>fat-2(wa17</italic>). Worms were homozygous for all indicated genotypes, but note that the <italic>hif-1(et69)</italic> allele suppresses <italic>fat-2(wa17)</italic> best in a heterozygous state. (<bold>B</bold>) Heat map analysis of PC species in suppressor mutants. (<bold>C</bold>) Levels of individual FA species in PCs in <italic>fat-2(wa17</italic>) suppressors, the insert shows that levels of C20:5 are significantly increased in all double mutant strains. n=4 populations for each genotype. For A and C (inset), *p&lt;0.05, **p&lt;0.01, ***p&lt;0.001 indicate significant differences compared to the <italic>fat-2(wa17)</italic> control and using one-way ANOVA followed by a Dunnett’s multiple comparison test. Note that the N2 and <italic>fat-2(wa17)</italic> samples are the same as in <xref ref-type="fig" rid="fig3">Figure 3</xref>.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-104181-fig7-v1.tif"/></fig><fig id="fig7s1" position="float" specific-use="child-fig"><label>Figure 7—figure supplement 1.</label><caption><title>Lipidomics of phosphatidylethanolamines (PEs) in <italic>fat-2(wa17)</italic> suppressors.</title><p>(<bold>A</bold>) Levels of saturated fatty acids (SFAs), monounsaturated fatty acids (MUFAs), and polyunsaturated fatty acids (PUFAs) in PEs measured in <italic>fat-2(wa17)</italic> suppressors confirm that the suppressors increase PUFA levels in <italic>fat-2(wa17</italic>). (<bold>B</bold>) Heat map analysis of PE species in suppressor mutants. (<bold>C</bold>) Levels of individual FA species in PEs in <italic>fat-2(wa17</italic>) suppressors, the insert shows that levels of 20:5 are increased in all double mutant strains. n=4 populations for each genotype. For A and C (inset), *p&lt;0.05, **p&lt;0.01, ***p&lt;0.001 indicate significant differences compared to the <italic>fat-2(wa17)</italic> control and using one-way ANOVA followed by a Dunnett’s multiple comparison test.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-104181-fig7-figsupp1-v1.tif"/></fig></fig-group></sec><sec id="s2-5"><title>Multiple stress response pathways are active in <italic>fat-2(wa17)</italic> and suppressed by <italic>ftn-2(et68)</italic></title><p>The increase in EPA, and PUFA levels in general, likely explains the improved development and growth of <italic>fat-2(wa17)</italic>. We examined other traits that may be rescued by the <italic>fat-2</italic> suppressors, using the <italic>ftn-2(et68)</italic> mutant as a representative because the <italic>egl-9</italic> and <italic>hif-1</italic> alleles converge on it. We found that the membrane fluidity defects in <italic>fat-2(wa17)</italic> were suppressed by <italic>ftn-2(et68)</italic> (<xref ref-type="fig" rid="fig8">Figure 8A–C</xref>). Additionally, several stress response pathways that are constitutively activated in the <italic>fat-2(wa17)</italic> mutant were also rescued by <italic>ftn-2(et68)</italic>. The mitochondrial UPR visualized with a <italic>hsp-60::GFP</italic> reporter (<xref ref-type="bibr" rid="bib91">Yoneda et al., 2004</xref>) is activated in <italic>fat-2(wa17)</italic> at a level similar to that in <italic>afts-1(et15)</italic>, a known activator of mitochondrial stress (<xref ref-type="bibr" rid="bib62">Rauthan et al., 2013</xref>), and this is suppressed by <italic>ftn-2(et68)</italic> (<xref ref-type="fig" rid="fig8">Figure 8D–E</xref>). Similarly, the metabolic stress reporter DAF-16::GFP (<xref ref-type="bibr" rid="bib45">Libina et al., 2003</xref>) is constitutively nuclear-localized in <italic>fat-2(wa17),</italic> and this is also suppressed by <italic>ftn-2(et68)</italic> (<xref ref-type="fig" rid="fig8">Figure 8F–G</xref>). Using a <italic>hsp-4::GFP</italic> reporter (<xref ref-type="bibr" rid="bib9">Calfon et al., 2002</xref>), we found that the ER UPR is only slightly activated in <italic>fat-2(wa17)</italic> relative to WT (especially in spermatheca), and that this stress response too is partially suppressed by <italic>ftn-2(et68)</italic> (<xref ref-type="fig" rid="fig8">Figure 8H–I</xref>). Altogether, these results show that the PUFA-deficient <italic>fat-2(wa17)</italic> mutant engages multiple stress response pathways and that these are abated by <italic>ftn-2(et68</italic>).</p><fig id="fig8" position="float"><label>Figure 8.</label><caption><title><italic>ftn-2(et68)</italic> rescues <italic>fat-2(wa17</italic>)’s stress responses.</title><p>(<bold>A</bold>) Representative image of a fluorescence recovery after photobleaching (FRAP) experiment, showing pGLO-1::GFP-CAAX-positive intestinal membranes. The rectangle indicates the bleached area. (<bold>B–C</bold>) T<sub>half</sub> values and FRAP curves show that <italic>ftn-2(et68);fat-2(wa17)</italic> has less rigid membranes than <italic>fat-2(wa17).</italic> From left to right, n=7, 9, 10. (<bold>D–E</bold>) Representative images and quantification of <italic>ftn-2(et68)</italic> rescue of <italic>fat-2(wa17)</italic> mitochondrial stress with a <italic>hsp-60::gfp</italic> reporter. <italic>atfs-1(et15)</italic> serves as a control for high mitochondrial UPR activation. n=20 for each genotype. (<bold>F–G</bold>) Representative images and quantification of DAF-16::GFP localization showing that the DAF-16 stress response is constitutively active in the <italic>fat-2(wa17)</italic> mutant but normalized by <italic>ftn-2(et68</italic>). Chi-squared test shows that <italic>fat-2(wa17)</italic> is significantly different from wild-type (WT). n=100 for each genotype. (<bold>H–I</bold>) Representative images and quantification of mild ER stress in <italic>fat-2(wa17)</italic> that is slightly rescued by <italic>ftn-2(et68</italic>) using a <italic>hsp-4::gfp</italic> reporter. n=20 for each genotype. *p&lt;0.05, **p&lt;0.01, ***p&lt;0.001 indicate significant differences compared to the <italic>fat-2(wa17)</italic> control (ordinary one-way ANOVA with Tukey multiple comparisons test).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-104181-fig8-v1.tif"/></fig></sec><sec id="s2-6"><title>Mimicking <italic>fat-2(wa17)</italic> suppressors using hypoxia or iron supplements</title><p>Attempts to mimic the effects of the <italic>fat-2(wa17)</italic> suppressor mutations by hypoxia or supplement treatments were only partially successful. Providing <italic>fat-2(wa17)</italic> with ferric ammonium citrate (FAC), which increases the levels of ferric ions that can be converted into ferrous ions as well as overall iron levels in worms (<xref ref-type="bibr" rid="bib81">Valentini et al., 2012</xref>), provided only a slight rescue of the <italic>fat-2(wa17)</italic> mutant (<xref ref-type="fig" rid="fig9">Figure 9A</xref>). Additionally, providing <italic>fat-2(wa17)</italic> with ferrous ions in the form of ferrous chloride did not provide any rescue (<xref ref-type="fig" rid="fig9s1">Figure 9—figure supplement 1A</xref>). Reducing the levels of ferrous ions with the iron chelator deferoxamine, which we hypothesized would further hinder <italic>fat-2(wa17)</italic> growth, had no effect (<xref ref-type="fig" rid="fig9s1">Figure 9—figure supplement 1B</xref>); however, given that the <italic>fat-2(syb7458)</italic> null mutant grows at the same rate as <italic>fat-2(wa17)</italic> in 72 hr (<xref ref-type="fig" rid="fig9s1">Figure 9—figure supplement 1C</xref>) but never develops into an adult, we theorize that 72 hr may be too short to see a negative effect from deferoxamine on <italic>fat-2(wa17)</italic>. HIF-1-activating paraquat (PQ; <xref ref-type="bibr" rid="bib32">Hwang et al., 2014</xref>) likewise conferred only a small rescue (<xref ref-type="fig" rid="fig9">Figure 9B</xref>), while the combination of FAC and PQ did not provide any additional growth rescue, both at 20°C and 25°C (<xref ref-type="fig" rid="fig9">Figure 9C</xref>; <xref ref-type="fig" rid="fig9s1">Figure 9—figure supplement 1D</xref>). The HIF-1 activator hydrogen peroxide (<xref ref-type="bibr" rid="bib88">Xie and Roy, 2012</xref>) also only mildly rescued <italic>fat-2(wa17)</italic> (<xref ref-type="fig" rid="fig9">Figure 9D</xref>), while two separate hypoxia mimetics (cobalt chloride [<xref ref-type="bibr" rid="bib55">Padmanabha et al., 2015</xref>] and sodium sulfite [<xref ref-type="bibr" rid="bib37">Jiang et al., 2011</xref>]) did not suppress the poor growth of <italic>fat-2(wa17)</italic> (<xref ref-type="fig" rid="fig9s1">Figure 9—figure supplement 1E–F</xref>). Additionally, exposing <italic>fat-2(wa17)</italic> to multiple short hypoxia treatments slightly increased growth, but longer hypoxia treatments had no effect (<xref ref-type="fig" rid="fig9">Figure 9E</xref>). Finally, we also tested a cocktail of eicosanoids, which are derived from PUFAs such as EPA and could be limiting in the <italic>fat-2(wa17)</italic> mutant, but found that they had no rescuing effect when added as a supplement to the culture plates; their half-life and uptake by the worms are unknown (<xref ref-type="fig" rid="fig9s1">Figure 9—figure supplement 1G</xref>). Taken together, these results suggest that increasing iron and activating HIF-1 are beneficial to <italic>fat-2(wa17)</italic>, but that achieving physiologically optimal dosing via experimental treatments is difficult.</p><fig-group><fig id="fig9" position="float"><label>Figure 9.</label><caption><title>Exogenous treatments that mimic <italic>fat-2(wa17)</italic> suppressors partially rescue <italic>fat-2(wa17)</italic>.</title><p>(<bold>A</bold>–<bold>E</bold>) Length assay of <italic>fat-2(wa17)</italic> cultivated with different treatments for 72 hr after L1 stage synchronization. The horizontal dashed line represents the approximate length of L1 worms at the start of each experiment. n=20 for each genotype/condition. *p&lt;0.05, **p&lt;0.01, ***p&lt;0.001 indicate significant differences compared to the <italic>fat-2(wa17)</italic> control (ordinary one-way ANOVA with Tukey multiple comparisons test).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-104181-fig9-v1.tif"/></fig><fig id="fig9s1" position="float" specific-use="child-fig"><label>Figure 9—figure supplement 1.</label><caption><title>Exogenous treatment of <italic>fat-2(wa17)</italic> to mimic suppressors.</title><p>(<bold>A–E</bold>) Length of <italic>fat-2(wa17)</italic> treated with various diets for 72 hr after L1 synchronization, attempting to mimic effects of <italic>egl-9</italic>, <italic>ftn-2</italic>, and <italic>hif-1</italic> suppressors. Horizontal dashed line represents the approximate size of worms at the start of each experiment. n=20 for each genotype/condition. *p&lt;0.05, **p&lt;0.01, ***p&lt;0.001 indicate significant differences compared to the <italic>fat-2(wa17)</italic> control (ordinary one-way ANOVA with Tukey multiple comparisons test).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-104181-fig9-figsupp1-v1.tif"/></fig></fig-group></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>That dietary PUFAs are essential for mammalian health, with LA and ALA acting as precursors for the synthesis of other PUFAs, is known since the 1930s (<xref ref-type="bibr" rid="bib6">Burr and Burr, 1930</xref>). PUFAs have been linked to several important cellular and physiological processes (reviewed in <xref ref-type="bibr" rid="bib8">Calder, 2012</xref>; <xref ref-type="bibr" rid="bib83">Vrablik and Watts, 2013</xref>; <xref ref-type="bibr" rid="bib26">Harayama and Shimizu, 2020</xref>), including cell membrane properties and organelle dynamics (<xref ref-type="bibr" rid="bib1">Antonny et al., 2015</xref>), autophagy (<xref ref-type="bibr" rid="bib54">O’Rourke et al., 2013</xref>), mitochondria function (<xref ref-type="bibr" rid="bib75">Stanley et al., 2012</xref>), ferroptosis (<xref ref-type="bibr" rid="bib90">Yang et al., 2016</xref>; <xref ref-type="bibr" rid="bib43">Lee et al., 2020</xref>; <xref ref-type="bibr" rid="bib59">Perez et al., 2020</xref>), regulation of the <italic>daf-2/</italic>insulin, mTOR and p38-MAPK pathways (<xref ref-type="bibr" rid="bib28">Horikawa and Sakamoto, 2010</xref>; <xref ref-type="bibr" rid="bib10">Chamoli et al., 2020</xref>; <xref ref-type="bibr" rid="bib46">Liu et al., 2020</xref>), SREBP stability and signaling (<xref ref-type="bibr" rid="bib86">Worgall et al., 1998</xref>; <xref ref-type="bibr" rid="bib89">Yahagi et al., 1999</xref>), lipid droplet fusion (<xref ref-type="bibr" rid="bib84">Wang et al., 2022</xref>), neuronal signaling and neurotransmission (<xref ref-type="bibr" rid="bib39">Kahn-Kirby et al., 2004</xref>; <xref ref-type="bibr" rid="bib48">Marza and Lesa, 2006</xref>; <xref ref-type="bibr" rid="bib82">Vásquez et al., 2014</xref>), TRPV-dependent sensory signaling (<xref ref-type="bibr" rid="bib39">Kahn-Kirby et al., 2004</xref>), oocyte development (<xref ref-type="bibr" rid="bib12">Chen et al., 2016</xref>), and telomere length (<xref ref-type="bibr" rid="bib87">Wu et al., 2024</xref>). Which of these, if any, is the specific essential role of PUFAs in animal physiology? And are there molecular mechanisms that can compensate for PUFA deficiency? In the present study, we approached these questions using forward genetics in <italic>C. elegans</italic>. While <italic>C. elegans</italic> can de novo synthesize PUFAs, mutations that impair the production of certain PUFAs can lead to developmental defects or lethality (<xref ref-type="bibr" rid="bib85">Watts and Browse, 2002</xref>; <xref ref-type="bibr" rid="bib15">Dancy et al., 2015</xref>; <xref ref-type="bibr" rid="bib58">Perez and Van Gilst, 2008</xref>), offering opportunities for suppressor screens. Here, we showed that defects in the <italic>fat-2(wa17)</italic> mutant, which has limited Δ12 desaturase activity and only produces trace amounts of PUFAs, are suppressed by either compensatory intragenic mutations within <italic>fat-2</italic> itself or by mutations within the HIF-1 pathway. The fact that screening approximately 40,000 haploid genomes for <italic>fat-2(wa17)</italic> suppressors and finding mutations only within <italic>fat-2</italic> itself or within the HIF-1 pathway suggests that the screen has reached near-saturation and that we may have identified most, if not all, possible genetic ways to compensate for the <italic>fat-2(wa17)</italic> mutation. Importantly, none of the <italic>fat-2(wa17)</italic> suppressor mutations that we identified compensate for the PUFA shortage itself. Instead, the <italic>fat-2(wa17)</italic> suppressors act by boosting desaturase activity to allow the <italic>fat-2(wa17)</italic> mutant to synthesize more PUFAs; the <italic>fat-2(wa17)</italic> suppressors, therefore, cannot suppress the defects of the <italic>fat-2</italic> null mutant, as we specifically showed for <italic>ftn-2(et68)</italic>. We draw the important conclusion that PUFAs are not only essential but also that their essential functions cannot be genetically replaced.</p><p>The <italic>fat-2(wa17)</italic> suppressor mutations within the HIF-1 pathway converge on the inhibition of <italic>ftn-2</italic>. The primary function of ferritin is to provide a harmless storage of iron within cells: ferritin promotes the oxidation of ferrous ions and stores the resulting ferric ions in a mineralized form (<xref ref-type="bibr" rid="bib61">Plays et al., 2021</xref>). Thus, <italic>ftn-2</italic> inhibition results in reduced total cellular iron but increased levels of ferrous ions, i.e., Fe<sup>2+</sup> (<xref ref-type="bibr" rid="bib36">Jenkins et al., 2020</xref>; <xref ref-type="bibr" rid="bib57">Pekec et al., 2022</xref>). Importantly, ferrous ions are required for desaturase reactions, and increasing ferrous ion concentration is a potent way to increase activity because it accelerates the rate at which the desaturase cycles from the inactive post-reaction Fe<sup>3+</sup>-bound state to the active Fe<sup>2+</sup>-bound state (<xref ref-type="bibr" rid="bib71">Shen et al., 2023</xref>; <xref ref-type="bibr" rid="bib70">Shen et al., 2020</xref>). Because eukaryotic desaturases are all evolutionarily closely related (<xref ref-type="bibr" rid="bib74">Sperling et al., 2003</xref>) and act in essentially the same way, ferrous ions must also be potent FAT-2 activators and thus boost the output from the mutant FAT-2(S101F) protein produced by the <italic>fat-2(wa17)</italic> allele or from the reduced FAT-2 protein levels in <italic>fat-2</italic> RNAi-treated worms. Our findings suggest an elegant explanation for the observation that HIF-1 inhibits <italic>ftn-2</italic> expression in <italic>C. elegans</italic> (<xref ref-type="bibr" rid="bib65">Romney et al., 2011</xref>): this is likely an adaptive response to boost desaturase activity when oxygen or iron is limiting, ensuring a maximum output under adverse conditions. Fe<sup>2+</sup> and HIF may contribute to desaturase boost also in human since CytB5 (which supplies Fe<sup>2+</sup> to desaturases) promotes SFA tolerance while VHL (which causes HIF degradation) prevents SFA tolerance in cultured cells (<xref ref-type="bibr" rid="bib94">Zhu et al., 2019</xref>). Other mechanisms are also possible. For example, mutations in the HIF-1 pathway could somehow reduce EPA turnover rates in the <italic>fat-2(wa17)</italic> mutant and allow its levels to rise above an essential threshold. This hypothesis is consistent with the observation that the suppressors can rescue both the <italic>fat-2(wa17)</italic> mutant and <italic>fat-2</italic> RNAi-treated worms but not the <italic>fat-2</italic> null mutant. It is even possible, though deemed unlikely, that the <italic>fat-2(wa17)</italic> suppressors act by compensating for the PUFA shortage via some undefined separate process downstream of the lipid changes and that they only indirectly result in elevated EPA levels.</p><p>Lipidomic analysis showed that among all PUFAs, it was the EPA levels that were best restored by the <italic>fat-2(wa17)</italic> suppressors. It is likely that any LA molecule produced in the mutants is quickly acted upon by downstream desaturases and elongases, leading to increased levels of the end product, namely EPA. EPA may be a sufficient or particularly important PUFA for sustaining <italic>C. elegans</italic> health, given that the <italic>fat-2(wa17)</italic> mutant is well rescued by EPA supplements. Indeed, DHA, which is not produced by <italic>C. elegans</italic>, is also able to rescue the <italic>fat-2(wa17)</italic> mutant. Others have shown that supplementing nearly completely EPA-deficient <italic>fat-3 C. elegans</italic> mutants with DHA significantly restored their EPA levels, suggesting that DHA supplements reduce EPA turnover (<xref ref-type="bibr" rid="bib44">Lesa et al., 2003</xref>). EPA and DHA, being long chain PUFAs should have similar fluidizing effects on membrane properties (though in vitro experiments challenge this view; <xref ref-type="bibr" rid="bib72">Sherratt et al., 2021</xref>), and both can serve as precursors of eicosanoids or docosanoids, particularly inflammatory ones (<xref ref-type="bibr" rid="bib13">Chiang and Serhan, 2020</xref>). Abundant literature indicates that EPA is a particularly important PUFA in <italic>C. elegans</italic>. Phosphatidylcholines containing two attached EPA molecules are very abundant in <italic>C. elegans</italic> membranes, and their abundance increases the most in response to a temperature shift from 25–15°C, suggesting an important role in fluidity homeostasis (<xref ref-type="bibr" rid="bib80">Tanaka et al., 1999</xref>). Long chain PUFAs such as EPA are required for efficient neurotransmission in <italic>C. elegans</italic>: mutants unable to produce them have depleted levels of synaptic vesicles accompanied by poor motility, and these defects are rescued by exogenous PUFAs, including DHA (<xref ref-type="bibr" rid="bib44">Lesa et al., 2003</xref>). <italic>C. elegans</italic> can also convert EPA to eicosanoids in a cytochrome P450-dependent manner (<xref ref-type="bibr" rid="bib42">Kulas et al., 2008</xref>; <xref ref-type="bibr" rid="bib50">Mokoena et al., 2020</xref>); inhibiting this process results in reduced pharyngeal pumping rate, suggesting that regulation of muscular contraction by eicosanoids is conserved from nematodes to mammals (<xref ref-type="bibr" rid="bib41">Kosel et al., 2011</xref>). EPA-derived eicosanoids are also required for guiding some cell migrations in <italic>C. elegans</italic>, including that of sperm (<xref ref-type="bibr" rid="bib27">Hoang et al., 2013</xref>). EPA, and other PUFAs, can inhibit the nuclear localization of DAF-16 in <italic>fat-2-</italic>RNAi-treated worms, suggesting that they mediate signaling via this insulin receptor homolog and thus generally promote growth in <italic>C. elegans</italic> rather than stress resistance and fat storage (<xref ref-type="bibr" rid="bib28">Horikawa and Sakamoto, 2010</xref>). In conclusion, EPA is clearly an important PUFA in <italic>C. elegans,</italic> and our work suggests that its multifaceted functions cannot be replaced by mutations in any one gene.</p><p>Finally, the case of the three novel <italic>egl-9</italic> alleles isolated in our screen deserves special attention. All three alleles specifically affect the arginine at position 557 of the EGL-9 protein (it is converted to a histidine in two of the alleles, and to a cysteine in the third). This Arg557 in EGL-9 is specifically required for its ability to hydroxylate HIF-1, thus marking it for ubiquitin-dependent degradation (<xref ref-type="bibr" rid="bib23">Epstein et al., 2001</xref>). Null alleles of <italic>egl-9</italic> were not picked in our screen, and directly testing such a null allele revealed it to be ineffective as a <italic>fat-2(wa17)</italic> suppressor. We conclude that the EGL-9 proteins bearing a mutation at position Arg557 retain important functions while being unable to hydroxylate HIF-1. Others have previously demonstrated that EGL-9 could inhibit HIF-1 even when unable to hydroxylate it (<xref ref-type="bibr" rid="bib69">Shao et al., 2009</xref>). Clearly, there is more to EGL-9 than its function as a HIF-1 hydroxylase, and it would be interesting in the future to detail this further.</p><p>We conclude that PUFA-deficient <italic>fat-2(wa17)</italic> mutants benefit only slightly from membrane-fluidizing treatments, and that there is likely no genetic way to compensate for PUFA deficiency. <italic>fat-2(wa17)</italic> mutants can only be rescued by boosting the activity of its defective desaturase, and restoring EPA levels are likely sufficient to suppress most <italic>fat-2(wa17)</italic> phenotypes suggesting a particularly important role for this PUFA in <italic>C. elegans.</italic> In the future, it will be interesting to determine if boosting desaturase activity by inhibition of ferritin expression via HIF-1 is also a beneficial response to hypoxia in worms and humans.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><sec id="s4-1"><title><italic>C. elegans</italic> strains and cultivation</title><p>The wild-type <italic>C. elegans</italic> reference strain N2, <italic>fat-2(wa17), nhr-49(et8), mdt-15(et14), paqr-1(et52), paqr-2(3410), acs-13(et54), fld-1(et46), hif-1(ok2564), ftn-2(ok404), ftn-1(ok3625), egl-9(sa307), atfs-1(et15), zcIs4 [hsp-4::GFP], zcIs9 [hsp-60::GFP +lin-15(+)]</italic> and <italic>zIs356 [daf-16p::daf-16a/b::GFP +rol-6(su1006)]</italic> are available from the <italic>C. elegans</italic> Genetics Center (CGC; USA). The PHX7548 (<italic>fat-2(syb7458)/nT1[qIs51]</italic>(IV;V)) strain was created by Suny Biotech Co using CRISPR/Cas9 and carries a deletion of 1387 bp between flanking sequences 5’-<named-content content-type="sequence">aaacttggcccccgacgaagatg</named-content>-3’ and 5’-<named-content content-type="sequence">gtgataatgacgagaataagtcct</named-content>-3’. <italic>fat-2(syb7458)</italic> worms were maintained in an unbalanced state on non-peptone plates containing OP50 grown overnight in LB containing 2 mM linoleic acid.</p><p>Unless otherwise stated, experiments were performed at 20 °C, using the <italic>E. coli</italic> strain OP50 as a food source, which was re-streaked every 6–8 wk and maintained on LB plates at 4°C. Single colonies were cultivated overnight at 37 °C in LB medium before being used to seed NGM plates. Stock solutions of supplements were filter-sterilized and added to cooled NGM after autoclaving to produce supplement plates.</p></sec><sec id="s4-2"><title>Construction of <italic>fat-2(+)</italic></title><p>The <italic>pfat-2(+)</italic> construct was generated with the NEB PCR Cloning Kit for amplification of <italic>fat-2(+)</italic> with the following primers: 5’-<named-content content-type="sequence">gagctcaagaagcgtttcca</named-content>-3’ and 5’-<named-content content-type="sequence">gggcaagaatttgtagtgtca</named-content>-3’ using N2 genomic DNA. Plasmids were prepared with a GeneJet Plasmid Miniprep Kit and injected at the following concentrations: <italic>pfat-2(+)</italic> of 20 µg/µl, <italic>pRF4(rol-6)</italic> of 40 µg/µl, and <italic>pBSKS</italic> of 35 µg/µl into <italic>fat-2(wa17)</italic> and N2 worms.</p></sec><sec id="s4-3"><title>Pre-loading of <italic>E. coli</italic> with fatty acids or eicosanoids</title><p>Stock solutions of fatty acids (Merck) or eicosanoids (Primary Eicosanoid HPLC Mixture; Cayman Chemical) dissolved in ethanol (EPA, DHA, OA), DMSO (LA), or methyl acetate (eicosanoids) were diluted in LB media to the appropriate final concentration, inoculated with OP50 bacteria, and shaken overnight at 37 °C. The bacteria were washed twice in M9 to remove fatty acids, concentrated 10 X by centrifugation, dissolved in LB, and seeded onto NGM plates lacking peptone.</p></sec><sec id="s4-4"><title>Growth assays</title><p>For length measurement studies, synchronized L1s were plated onto test plates seeded with OP50, and worms were mounted and photographed 72 hr later. Experiments performed at 15 °C were photographed after 144 hr. The length of 20 worms was measured using ImageJ.</p><p>For hydrogen peroxide treatment, synchronized worms were incubated in 2 mM hydrogen peroxide for 2 hr at the L1 stage before being plated on NGM plates for 72 hr. For hypoxia treatment, synchronized L1s were incubated for 2–6 hr in a hypoxia chamber, returned to normoxia for 24 hr, and hypoxia exposure was repeated as stated in the figure.</p></sec><sec id="s4-5"><title>Oil Red O staining</title><p>Synchronized day 1 adults were washed three times with PBST and fixed for 3 min in 60% isopropanol. Worms were then rotated for 2 hr in filtered 60% Oil Red O staining solution. The stained worms were washed three times in PBST before being mounted on agarose pads and imaged with a Zeiss Axioscope microscope.</p></sec><sec id="s4-6"><title>Mutagenesis and screen for <italic>fat-2(wa17)</italic> suppressors</title><p><italic>fat-2(wa17)</italic> worms were mutagenized for 4 hr by incubation in the presence of 0.05 M ethyl methane sulfonate (EMS) according to the standard protocol (<xref ref-type="bibr" rid="bib76">Sulston and Hodgkin, 1988</xref>). The worms were then washed and spotted onto an NGM plate. After 2 hr, L4 hermaphrodite animals were transferred to new plates. 8–10 d later, F1 progeny were bleached, washed, and their eggs allowed to hatch overnight in M9. The resulting L1 larvae were spotted onto new plates, cultivated at 20 °C, then screened after 72 hr for gravid F2 worms, which were then picked to new plates for further analysis. In total, approximately 40, 000 independently mutagenized haploid genomes were screened. The isolated suppressor mutants were outcrossed 4–6 times prior to whole genome sequencing, and 8–10 times prior to characterization. Outcrossing was done by mating N2 males to a suppressor, then crossing male progeny to <italic>fat-2(wa17)</italic> mutant worms. Progeny from this cross were picked to individual plates and kept at 20 °C, then screened for <italic>fat-2(wa17)</italic> homozygosity using PCR, followed by testing the F2 progeny for ability to grow to adults in 72 hr. Genotyping primers for the suppressor mutants are included in <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>.</p></sec><sec id="s4-7"><title>Whole genome sequencing</title><p>The genomes of the ten suppressor mutants that had been outcrossed 4 or 6 times were sequenced by Eurofins (Constance, Germany) with a mean coverage varying from 40.68X to 63.05X and their genomes assembled using the <italic>C. elegans</italic> genome version cel235 from Ensembl (REF: PMID: 37953337). Eurofins applied customised filters to the variants to filter false positives using GATK’s Variant Filtration module (<xref ref-type="bibr" rid="bib16">DePristo et al., 2011</xref>; <xref ref-type="bibr" rid="bib49">McKenna et al., 2010</xref>). Variants detected were annotated based on their gene context using snpEff (<xref ref-type="bibr" rid="bib14">Cingolani et al., 2012</xref>). For each suppressor mutant, one or two hot spots, i.e., small genomic area containing several mutations, were identified and candidate mutations tested experimentally as described in the text.</p></sec><sec id="s4-8"><title>CRISPR-Cas9 genome editing</title><p>The recreation of the candidate suppressor mutations and insertion of the 3xFLAG tag into the <italic>hif-1</italic> gene was performed using CRISPR-Cas9 gene editing as previously described (<xref ref-type="bibr" rid="bib24">Ghanta and Mello, 2020</xref>; <xref ref-type="bibr" rid="bib20">Dokshin et al., 2018</xref>). The insertion of the ssDNA oligos was performed utilizing the homology-directed repair (HDR) mechanisms. The protospacer-adjacent motif (PAM) site of the ssDNA oligo template was flanked by 40 bp homology arms. Design and synthesis of the ssDNA and CRISPR RNA (crRNA) was performed using the Alt-R HDR Design Tool from IDT (Integrated DNA Technologies, Inc; Coralville, IA, USA), including proprietary modifications that improve oligo stability. To recreate the <italic>hif-1(et69)</italic> allele, we used the crRNA sequence 5’- UUUCUUAACGUGUGUAUUUCGUUUUAGAGCUAUGCU-3’ and the DNA oligo donor sequence 5’-<named-content content-type="sequence">AGTTCCATACATTTAGCAAGTGATTTCTTAACGTGTGTATTTCAAGAGCACGTAAGAACAGCTACGATGACGTTTTGCAATGGCT</named-content>-3. To introduce the 3xFLAG at the N-terminus coding end of <italic>hif-1,</italic> we used the crRNA sequence 5’- GAAAAUAAUCAAGAGAGCAUGUUUUAGAGCUAUGCU-3’ and the DNA oligo donor sequence 5’-<named-content content-type="sequence">AAATGAACAACAGCCTAGTTCTTATTCCCCATTTCCAATGCTCTCTGACTACAAGGACCACGACGGCGATTATAAGGATCACGACATCGACTACAAAGACGACGATGACAAGTGATTATTTTCTACCCCCTCTCAAACTGTTCATTGTTTTG</named-content>-3’. The injection mixes were prepared using 10 μg/μl of the Cas9 enzyme (IDT), 0.4 μg/μl tracrRNA (IDT), 2.8 0.4 μg/μl crRNA (IDT), 1 μg/μl of ssDNA (IDT), and 40 ng/μl of PRF4(<italic>rol-6</italic>) or Pmyo-2(GFP) plasmid. The mixture was microinjected into the posterior gonad of the worm and the F1 generation was screened for animals expressing the reporter plasmid. Genotypes were tested by PCR and successfully edited genes were confirmed by Sanger sequencing (Eurofins).</p></sec><sec id="s4-9"><title>Fluorescence recovery after photobleaching (FRAP)</title><p>FRAP experiments were carried out using a membrane-associated prenylated GFP reporter expressed in intestinal cells as previously described (<xref ref-type="bibr" rid="bib18">Devkota and Pilon, 2018</xref>), using a Zeiss LSM700inv laser scanning confocal microscope with a 40 X water immersion objective. Briefly, the GFP-positive membranes were photobleached over a rectangular area (30×4 pixels) using 30 iterations of the 488 nm laser with 50% laser power transmission. Images were collected at a 12-bit intensity resolution over 256×256 pixels (digital zoom 4 X) using a pixel dwell time of 1.58 µs, and were all acquired under identical settings. The recovery of fluorescence was traced for 25 s. Fluorescence recovery and T<sub>half</sub> were calculated as previously described (<xref ref-type="bibr" rid="bib78">Svensk et al., 2016</xref>).</p></sec><sec id="s4-10"><title>Stress response assay</title><p>Worms were imaged with a Zeiss Axioscope and fluorescence intensity was quantified with ImageJ (n≥20 for all experiments). Worm strains carrying <italic>hsp-60::GFP</italic> were imaged as day 1 adults, and the fluorescence values were taken from a 39 μm circumference circle in the brightest part of the anterior part of the worm. Worm strains carrying <italic>DAF-16::GFP</italic> were imaged as L4s and the percentage of worms with cytoplasmic or nuclear localization was quantified. Worm strains carrying <italic>hsp-4::GFP</italic> were imaged as day 1 adults and the fluorescence of the whole worm was quantified.</p></sec><sec id="s4-11"><title>Lipidomics</title><p>Samples were composed of synchronized L4 larvae (one 9 cm diameter plate/sample; each treatment/genotype was prepared in four independently grown replicates) grown on NGM or non-peptone plates seeded with linoleic acid. In the case of LA to NGM samples, worms were grown until late L3/early L4 stage on linoleic acid seeded non-peptone plates before being transferred to NGM plates for 6 hr before collection. Worms were washed three times in M9, pelleted and stored at –80 °C until analysis. For lipid extraction, the pellet was sonicated for 10 min in methanol;butanol [1:3] and then extracted according to published methods (<xref ref-type="bibr" rid="bib47">Löfgren et al., 2016</xref>). Lipid extracts were evaporated and reconstituted in chloroform:methanol [1:2] with 5 mM ammonium acetate. This solution was infused directly (shotgun approach) into a QTRAP 5500 mass spectrometer (Sciex) equipped with a TriVersa NanoMate (Advion Bioscience) as described previously (<xref ref-type="bibr" rid="bib38">Jung et al., 2011</xref>). Phospholipids were measured using precursor ion scanning in negative mode using the fatty acids as fragments (<xref ref-type="bibr" rid="bib22">Ekroos et al., 2003</xref>; <xref ref-type="bibr" rid="bib21">Ejsing et al., 2009</xref>). To generate the phospholipid composition (as mol%), the signals from individual phospholipids (area under the m/z peak in the spectra) were divided by the signal from all detected phospholipids of the same class. The data were evaluated using the LipidView software (Sciex). The data were further analyzed using Qlucore Omics Explorer n.n (Qlucore AB) for analysis. The data were normalized for the purpose of the heat map visualization (mean = 0; variance = 1).</p></sec><sec id="s4-12"><title>Protein extraction and western blots</title><p>Worms were lysed using lysis buffer containing 25 mM Tris (pH 7.5), 300 mM NaCl, 0.1% NP40, and 1 X protease inhibitor on ice with a motorized pestle. Samples were centrifuged at 20,000 g for 15 min at 4°C, and protein sample concentration was quantified using the BCA protein assay kit. 15 µg of protein were mixed with Laemmli sample loading buffer containing β-mercaptoethanol, boiled for 10 min, and loaded in 4–20% gradient precast SDS gel. After electrophoresis, the proteins were transferred to nitrocellulose membranes using Trans-Blot Turbo Transfer Packs and a Trans-Blot Turbo apparatus/predefined mixed-MW program. Blots were blocked in 5% nonfat dry milk in PBST for 1 hr at room temperature. Blots were incubated with primary antibodies overnight at 4 °C (mouse monoclonal anti-FLAG antibody (M2, Sigma Aldrich) 1:5000 dilution) or 1 hr at room temperature (mouse monoclonal anti-alpha-Tubulin (B512, Sigma Aldrich) 1:5000 dilution). Blots were then washed with PBST and incubated with swine-anti-rabbit HRP 1:3000 dilution or goat anti-mouse HRP 1:3000 dilution for 1 hr at room temperature and washed again with PBST. Detection of the hybridized antibody was performed using an ECL detection kit (Immobilon Western, Millipore), and the signal was visualized with a digital camera (VersaDoc, Bio-Rad).</p></sec><sec id="s4-13"><title>Quantitative PCR (qPCR)</title><p>Total cellular worm RNA was isolated using the RNeasy Plus Kit according to the manufacturer’s instructions (Qiagen) and quantified using a NanoDrop spectrophotometer (ND-1000; Thermo Scientific). cDNA was obtained using the RevertAid H Minus First Strand cDNA Synthesis Kit (Thermo Scientific) with random hexamers. qPCR was performed with a CFX Connect thermal cycler (Bio-Rad) using HOT FIREpol EvaGreen qPCR SuperMix (Solis Biodyne) and standard primers. Samples were measured in triplicates. The relative expression of each gene was calculated according to the delta-delta CT method. Expression of the housekeeping gene <italic>tba-1</italic> was used to normalize for variations in RNA input. Primers used were as follows: <italic>ftn-2</italic>, forward (<named-content content-type="sequence">TACCACTCCGAGGTTGAAGC</named-content>) and reverse (<named-content content-type="sequence">TGGAAGGGCAACATCGTCAC</named-content>); <italic>tba-1</italic>, forward (<named-content content-type="sequence">TCTCGCAGGTTGTGTCTTCC</named-content>) and reverse (<named-content content-type="sequence">AGCCTCATGGTAAGCCTGAA</named-content>).</p></sec><sec id="s4-14"><title>Statistics</title><p>Error bars for the worm length measurements show the standard error of the mean, and one-way ANOVA tests were used to identify significant differences from <italic>fat-2(wa17)</italic> control, unless otherwise stated. All experiments were independently repeated at least twice with similar results, and the statistics shown apply to the presented experimental results.</p></sec><sec id="s4-15"><title>Materials availability statement</title><p>Strains generated in this study will be deposited at the <italic>Caenorhabditis</italic> Genetics Center (CGC). Strains, and other reagents, can also be requested from the corresponding author.</p></sec></sec></body><back><sec sec-type="additional-information" id="s5"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Data curation, Formal analysis, Investigation, Visualization, Writing – original draft, Writing – review and editing</p></fn><fn fn-type="con" id="con2"><p>Conceptualization, Data curation, Formal analysis, Investigation, Visualization</p></fn><fn fn-type="con" id="con3"><p>Investigation</p></fn><fn fn-type="con" id="con4"><p>Formal analysis, Investigation, Visualization</p></fn><fn fn-type="con" id="con5"><p>Investigation</p></fn><fn fn-type="con" id="con6"><p>Project administration</p></fn><fn fn-type="con" id="con7"><p>Conceptualization, Data curation, Formal analysis, Funding acquisition, Investigation, Visualization, Writing – original draft, Project administration, Writing – review and editing</p></fn></fn-group></sec><sec sec-type="supplementary-material" id="s6"><title>Additional files</title><supplementary-material id="supp1"><label>Supplementary file 1.</label><caption><title>Primers for genotyping.</title></caption><media xlink:href="elife-104181-supp1-v1.xlsx" mimetype="application" mime-subtype="xlsx"/></supplementary-material><supplementary-material id="mdar"><label>MDAR checklist</label><media xlink:href="elife-104181-mdarchecklist1-v1.docx" mimetype="application" mime-subtype="docx"/></supplementary-material></sec><sec sec-type="data-availability" id="s7"><title>Data availability</title><p>The targetted lipidomics data for Figures 3 and 7 (and their associated figure supplements) is provided as Source Data.</p></sec><ack id="ack"><title>Acknowledgements</title><p>Some strains were provided by the CGC, which is funded by the NIH Office of Research Infrastructure Programs (P40 OD010440). This research was funded by Cancerfonden (22 1984 Pj) and Vetenskapsrådet (2024–04012).</p></ack><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Antonny</surname><given-names>B</given-names></name><name><surname>Vanni</surname><given-names>S</given-names></name><name><surname>Shindou</surname><given-names>H</given-names></name><name><surname>Ferreira</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>From zero to six double bonds: phospholipid unsaturation and organelle function</article-title><source>Trends in Cell Biology</source><volume>25</volume><fpage>427</fpage><lpage>436</lpage><pub-id pub-id-type="doi">10.1016/J.TCB.2015.03.004</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barelli</surname><given-names>H</given-names></name><name><surname>Antonny</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Lipid unsaturation and organelle dynamics</article-title><source>Current Opinion in Cell Biology</source><volume>41</volume><fpage>25</fpage><lpage>32</lpage><pub-id pub-id-type="doi">10.1016/J.CEB.2016.03.012</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bazinet</surname><given-names>RP</given-names></name><name><surname>Layé</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Polyunsaturated fatty acids and their metabolites in brain function and disease</article-title><source>Nature Reviews. Neuroscience</source><volume>15</volume><fpage>771</fpage><lpage>785</lpage><pub-id pub-id-type="doi">10.1038/nrn3820</pub-id><pub-id pub-id-type="pmid">25387473</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bell</surname><given-names>MV</given-names></name><name><surname>Henderson</surname><given-names>RJ</given-names></name><name><surname>Sargent</surname><given-names>JR</given-names></name></person-group><year iso-8601-date="1986">1986</year><article-title>The role of polyunsaturated fatty acids in fish</article-title><source>Comparative Biochemistry and Physiology Part B</source><volume>83</volume><fpage>711</fpage><lpage>719</lpage><pub-id pub-id-type="doi">10.1016/0305-0491(86)90135-5</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bracken</surname><given-names>CP</given-names></name><name><surname>Fedele</surname><given-names>AO</given-names></name><name><surname>Linke</surname><given-names>S</given-names></name><name><surname>Balrak</surname><given-names>W</given-names></name><name><surname>Lisy</surname><given-names>K</given-names></name><name><surname>Whitelaw</surname><given-names>ML</given-names></name><name><surname>Peet</surname><given-names>DJ</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Cell-specific regulation of hypoxia-inducible factor (HIF)-1alpha and HIF-2alpha stabilization and transactivation in a graded oxygen environment</article-title><source>The Journal of Biological Chemistry</source><volume>281</volume><fpage>22575</fpage><lpage>22585</lpage><pub-id pub-id-type="doi">10.1074/jbc.M600288200</pub-id><pub-id pub-id-type="pmid">16760477</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burr</surname><given-names>GO</given-names></name><name><surname>Burr</surname><given-names>MM</given-names></name></person-group><year iso-8601-date="1930">1930</year><article-title>On the nature and rôle of the fatty acids essential in nutrition</article-title><source>Journal of Biological Chemistry</source><volume>86</volume><fpage>587</fpage><lpage>621</lpage><pub-id pub-id-type="doi">10.1016/S0021-9258(20)78929-5</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Busayavalasa</surname><given-names>K</given-names></name><name><surname>Ruiz</surname><given-names>M</given-names></name><name><surname>Devkota</surname><given-names>R</given-names></name><name><surname>Ståhlman</surname><given-names>M</given-names></name><name><surname>Bodhicharla</surname><given-names>R</given-names></name><name><surname>Svensk</surname><given-names>E</given-names></name><name><surname>Hermansson</surname><given-names>N-O</given-names></name><name><surname>Borén</surname><given-names>J</given-names></name><name><surname>Pilon</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Leveraging a gain-of-function allele of <italic>Caenorhabditis elegans</italic> PAQR-1 to elucidate membrane homeostasis by PAQR proteins</article-title><source>PLOS Genetics</source><volume>16</volume><elocation-id>e1008975</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1008975</pub-id><pub-id pub-id-type="pmid">32750056</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Calder</surname><given-names>PC</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Mechanisms of action of (n-3) fatty acids</article-title><source>The Journal of Nutrition</source><volume>142</volume><fpage>592S</fpage><lpage>599S</lpage><pub-id pub-id-type="doi">10.3945/jn.111.155259</pub-id><pub-id pub-id-type="pmid">22279140</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Calfon</surname><given-names>M</given-names></name><name><surname>Zeng</surname><given-names>H</given-names></name><name><surname>Urano</surname><given-names>F</given-names></name><name><surname>Till</surname><given-names>JH</given-names></name><name><surname>Hubbard</surname><given-names>SR</given-names></name><name><surname>Harding</surname><given-names>HP</given-names></name><name><surname>Clark</surname><given-names>SG</given-names></name><name><surname>Ron</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>IRE1 couples endoplasmic reticulum load to secretory capacity by processing the XBP-1 mRNA</article-title><source>Nature</source><volume>415</volume><fpage>92</fpage><lpage>96</lpage><pub-id pub-id-type="doi">10.1038/415092a</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chamoli</surname><given-names>M</given-names></name><name><surname>Goyala</surname><given-names>A</given-names></name><name><surname>Tabrez</surname><given-names>SS</given-names></name><name><surname>Siddiqui</surname><given-names>AA</given-names></name><name><surname>Singh</surname><given-names>A</given-names></name><name><surname>Antebi</surname><given-names>A</given-names></name><name><surname>Lithgow</surname><given-names>GJ</given-names></name><name><surname>Watts</surname><given-names>JL</given-names></name><name><surname>Mukhopadhyay</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Polyunsaturated fatty acids and p38-MAPK link metabolic reprogramming to cytoprotective gene expression during dietary restriction</article-title><source>Nature Communications</source><volume>11</volume><elocation-id>18690</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-020-18690-4</pub-id><pub-id pub-id-type="pmid">32978396</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cha’on</surname><given-names>U</given-names></name><name><surname>Valmas</surname><given-names>N</given-names></name><name><surname>Collins</surname><given-names>PJ</given-names></name><name><surname>Reilly</surname><given-names>PEB</given-names></name><name><surname>Hammock</surname><given-names>BD</given-names></name><name><surname>Ebert</surname><given-names>PR</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Disruption of iron homeostasis increases phosphine toxicity in <italic>Caenorhabditis elegans</italic></article-title><source>Toxicological Sciences</source><volume>96</volume><fpage>194</fpage><lpage>201</lpage><pub-id pub-id-type="doi">10.1093/toxsci/kfl187</pub-id><pub-id pub-id-type="pmid">17175555</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>WW</given-names></name><name><surname>Yi</surname><given-names>YH</given-names></name><name><surname>Chien</surname><given-names>CH</given-names></name><name><surname>Hsiung</surname><given-names>KC</given-names></name><name><surname>Ma</surname><given-names>TH</given-names></name><name><surname>Lin</surname><given-names>YC</given-names></name><name><surname>Lo</surname><given-names>SJ</given-names></name><name><surname>Chang</surname><given-names>TC</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Specific polyunsaturated fatty acids modulate lipid delivery and oocyte development in <italic>C. elegans</italic> revealed by molecular-selective label-free imaging</article-title><source>Scientific Reports</source><volume>6</volume><elocation-id>32021</elocation-id><pub-id pub-id-type="doi">10.1038/srep32021</pub-id><pub-id pub-id-type="pmid">27535493</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chiang</surname><given-names>N</given-names></name><name><surname>Serhan</surname><given-names>CN</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Specialized pro-resolving mediator network: an update on production and actions</article-title><source>Essays in Biochemistry</source><volume>64</volume><fpage>443</fpage><lpage>462</lpage><pub-id pub-id-type="doi">10.1042/EBC20200018</pub-id><pub-id pub-id-type="pmid">32885825</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cingolani</surname><given-names>P</given-names></name><name><surname>Platts</surname><given-names>A</given-names></name><name><surname>Wang</surname><given-names>LL</given-names></name><name><surname>Coon</surname><given-names>M</given-names></name><name><surname>Nguyen</surname><given-names>T</given-names></name><name><surname>Wang</surname><given-names>L</given-names></name><name><surname>Land</surname><given-names>SJ</given-names></name><name><surname>Lu</surname><given-names>X</given-names></name><name><surname>Ruden</surname><given-names>DM</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff: SNPs in the genome of <italic>Drosophila melanogaster</italic> strain w1118; iso-2; iso-3</article-title><source>Fly</source><volume>6</volume><fpage>80</fpage><lpage>92</lpage><pub-id pub-id-type="doi">10.4161/fly.19695</pub-id><pub-id pub-id-type="pmid">22728672</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dancy</surname><given-names>BCR</given-names></name><name><surname>Chen</surname><given-names>SW</given-names></name><name><surname>Drechsler</surname><given-names>R</given-names></name><name><surname>Gafken</surname><given-names>PR</given-names></name><name><surname>Olsen</surname><given-names>CP</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>13C- and 15N-Labeling strategies combined with mass spectrometry comprehensively quantify phospholipid dynamics in <italic>C. elegans</italic></article-title><source>PLOS ONE</source><volume>10</volume><elocation-id>e0141850</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0141850</pub-id><pub-id pub-id-type="pmid">26528916</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>DePristo</surname><given-names>MA</given-names></name><name><surname>Banks</surname><given-names>E</given-names></name><name><surname>Poplin</surname><given-names>R</given-names></name><name><surname>Garimella</surname><given-names>KV</given-names></name><name><surname>Maguire</surname><given-names>JR</given-names></name><name><surname>Hartl</surname><given-names>C</given-names></name><name><surname>Philippakis</surname><given-names>AA</given-names></name><name><surname>del Angel</surname><given-names>G</given-names></name><name><surname>Rivas</surname><given-names>MA</given-names></name><name><surname>Hanna</surname><given-names>M</given-names></name><name><surname>McKenna</surname><given-names>A</given-names></name><name><surname>Fennell</surname><given-names>TJ</given-names></name><name><surname>Kernytsky</surname><given-names>AM</given-names></name><name><surname>Sivachenko</surname><given-names>AY</given-names></name><name><surname>Cibulskis</surname><given-names>K</given-names></name><name><surname>Gabriel</surname><given-names>SB</given-names></name><name><surname>Altshuler</surname><given-names>D</given-names></name><name><surname>Daly</surname><given-names>MJ</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>A framework for variation discovery and genotyping using next-generation DNA sequencing data</article-title><source>Nature Genetics</source><volume>43</volume><fpage>491</fpage><lpage>498</lpage><pub-id pub-id-type="doi">10.1038/ng.806</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Devkota</surname><given-names>R</given-names></name><name><surname>Svensk</surname><given-names>E</given-names></name><name><surname>Ruiz</surname><given-names>M</given-names></name><name><surname>Ståhlman</surname><given-names>M</given-names></name><name><surname>Borén</surname><given-names>J</given-names></name><name><surname>Pilon</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>The adiponectin receptor AdipoR2 and its <italic>Caenorhabditis elegans</italic> homolog PAQR-2 prevent membrane rigidification by exogenous saturated fatty acids</article-title><source>PLOS Genetics</source><volume>13</volume><elocation-id>e1007004</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1007004</pub-id><pub-id pub-id-type="pmid">28886012</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Devkota</surname><given-names>R</given-names></name><name><surname>Pilon</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>FRAP: A powerful method to evaluate membrane fluidity in <italic>Caenorhabditis elegans</italic></article-title><source>Bio-Protocol</source><volume>8</volume><elocation-id>e2913</elocation-id><pub-id pub-id-type="doi">10.21769/BioProtoc.2913</pub-id><pub-id pub-id-type="pmid">34395742</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Devkota</surname><given-names>R</given-names></name><name><surname>Kaper</surname><given-names>D</given-names></name><name><surname>Bodhicharla</surname><given-names>R</given-names></name><name><surname>Henricsson</surname><given-names>M</given-names></name><name><surname>Borén</surname><given-names>J</given-names></name><name><surname>Pilon</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>A genetic titration of membrane composition in <italic>Caenorhabditis elegans</italic> reveals its importance for multiple cellular and physiological traits</article-title><source>Genetics</source><volume>219</volume><elocation-id>iyab093</elocation-id><pub-id pub-id-type="doi">10.1093/genetics/iyab093</pub-id><pub-id pub-id-type="pmid">34125894</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dokshin</surname><given-names>GA</given-names></name><name><surname>Ghanta</surname><given-names>KS</given-names></name><name><surname>Piscopo</surname><given-names>KM</given-names></name><name><surname>Mello</surname><given-names>CC</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Robust genome editing with short single-stranded and long, partially single-stranded DNA donors in <italic>Caenorhabditis elegans</italic></article-title><source>Genetics</source><volume>210</volume><fpage>781</fpage><lpage>787</lpage><pub-id pub-id-type="doi">10.1534/genetics.118.301532</pub-id><pub-id pub-id-type="pmid">30213854</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ejsing</surname><given-names>CS</given-names></name><name><surname>Sampaio</surname><given-names>JL</given-names></name><name><surname>Surendranath</surname><given-names>V</given-names></name><name><surname>Duchoslav</surname><given-names>E</given-names></name><name><surname>Ekroos</surname><given-names>K</given-names></name><name><surname>Klemm</surname><given-names>RW</given-names></name><name><surname>Simons</surname><given-names>K</given-names></name><name><surname>Shevchenko</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Global analysis of the yeast lipidome by quantitative shotgun mass spectrometry</article-title><source>PNAS</source><volume>106</volume><fpage>2136</fpage><lpage>2141</lpage><pub-id pub-id-type="doi">10.1073/pnas.0811700106</pub-id><pub-id pub-id-type="pmid">19174513</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ekroos</surname><given-names>K</given-names></name><name><surname>Ejsing</surname><given-names>CS</given-names></name><name><surname>Bahr</surname><given-names>U</given-names></name><name><surname>Karas</surname><given-names>M</given-names></name><name><surname>Simons</surname><given-names>K</given-names></name><name><surname>Shevchenko</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Charting molecular composition of phosphatidylcholines by fatty acid scanning and ion trap MS3 fragmentation</article-title><source>Journal of Lipid Research</source><volume>44</volume><fpage>2181</fpage><lpage>2192</lpage><pub-id pub-id-type="doi">10.1194/jlr.D300020-JLR200</pub-id><pub-id pub-id-type="pmid">12923235</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Epstein</surname><given-names>ACR</given-names></name><name><surname>Gleadle</surname><given-names>JM</given-names></name><name><surname>McNeill</surname><given-names>LA</given-names></name><name><surname>Hewitson</surname><given-names>KS</given-names></name><name><surname>O’Rourke</surname><given-names>J</given-names></name><name><surname>Mole</surname><given-names>DR</given-names></name><name><surname>Mukherji</surname><given-names>M</given-names></name><name><surname>Metzen</surname><given-names>E</given-names></name><name><surname>Wilson</surname><given-names>MI</given-names></name><name><surname>Dhanda</surname><given-names>A</given-names></name><name><surname>Tian</surname><given-names>YM</given-names></name><name><surname>Masson</surname><given-names>N</given-names></name><name><surname>Hamilton</surname><given-names>DL</given-names></name><name><surname>Jaakkola</surname><given-names>P</given-names></name><name><surname>Barstead</surname><given-names>R</given-names></name><name><surname>Hodgkin</surname><given-names>J</given-names></name><name><surname>Maxwell</surname><given-names>PH</given-names></name><name><surname>Pugh</surname><given-names>CW</given-names></name><name><surname>Schofield</surname><given-names>CJ</given-names></name><name><surname>Ratcliffe</surname><given-names>PJ</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title><italic>C. elegans</italic> EGL-9 and Mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation</article-title><source>Cell</source><volume>107</volume><fpage>43</fpage><lpage>54</lpage><pub-id pub-id-type="doi">10.1016/S0092-8674(01)00507-4</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ghanta</surname><given-names>KS</given-names></name><name><surname>Mello</surname><given-names>CC</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Melting dsDNA donor molecules greatly improves precision genome editing in <italic>Caenorhabditis elegans</italic></article-title><source>Genetics</source><volume>216</volume><fpage>643</fpage><lpage>650</lpage><pub-id pub-id-type="doi">10.1534/genetics.120.303564</pub-id><pub-id pub-id-type="pmid">32963112</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guillou</surname><given-names>H</given-names></name><name><surname>Zadravec</surname><given-names>D</given-names></name><name><surname>Martin</surname><given-names>PGP</given-names></name><name><surname>Jacobsson</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>The key roles of elongases and desaturases in mammalian fatty acid metabolism: Insights from transgenic mice</article-title><source>Progress in Lipid Research</source><volume>49</volume><fpage>186</fpage><lpage>199</lpage><pub-id pub-id-type="doi">10.1016/j.plipres.2009.12.002</pub-id><pub-id pub-id-type="pmid">20018209</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harayama</surname><given-names>T</given-names></name><name><surname>Shimizu</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Roles of polyunsaturated fatty acids, from mediators to membranes</article-title><source>Journal of Lipid Research</source><volume>61</volume><elocation-id>20000800</elocation-id><pub-id pub-id-type="doi">10.1194/JLR.R120000800</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoang</surname><given-names>HD</given-names></name><name><surname>Prasain</surname><given-names>JK</given-names></name><name><surname>Dorand</surname><given-names>D</given-names></name><name><surname>Miller</surname><given-names>MA</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>A heterogeneous mixture of F-series prostaglandins promotes sperm guidance in the <italic>Caenorhabditis elegans</italic> reproductive tract</article-title><source>PLOS Genetics</source><volume>9</volume><elocation-id>e1003271</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1003271</pub-id><pub-id pub-id-type="pmid">23382703</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Horikawa</surname><given-names>M</given-names></name><name><surname>Sakamoto</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Polyunsaturated fatty acids are involved in regulatory mechanism of fatty acid homeostasis via daf-2/insulin signaling in <italic>Caenorhabditis elegans</italic></article-title><source>Molecular and Cellular Endocrinology</source><volume>323</volume><fpage>183</fpage><lpage>192</lpage><pub-id pub-id-type="doi">10.1016/j.mce.2010.03.004</pub-id><pub-id pub-id-type="pmid">20226839</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>LE</given-names></name><name><surname>Arany</surname><given-names>Z</given-names></name><name><surname>Livingston</surname><given-names>DM</given-names></name><name><surname>Bunn</surname><given-names>HF</given-names></name></person-group><year iso-8601-date="1996">1996</year><article-title>Activation of hypoxia-inducible transcription factor depends primarily upon redox-sensitive stabilization of its alpha subunit</article-title><source>The Journal of Biological Chemistry</source><volume>271</volume><fpage>32253</fpage><lpage>32259</lpage><pub-id pub-id-type="doi">10.1074/jbc.271.50.32253</pub-id><pub-id pub-id-type="pmid">8943284</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>D</given-names></name><name><surname>Li</surname><given-names>T</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Sun</surname><given-names>L</given-names></name><name><surname>He</surname><given-names>X</given-names></name><name><surname>Zhong</surname><given-names>X</given-names></name><name><surname>Jia</surname><given-names>D</given-names></name><name><surname>Song</surname><given-names>L</given-names></name><name><surname>Semenza</surname><given-names>GL</given-names></name><name><surname>Gao</surname><given-names>P</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>HIF-1-mediated suppression of acyl-CoA dehydrogenases and fatty acid oxidation is critical for cancer progression</article-title><source>Cell Reports</source><volume>8</volume><fpage>1930</fpage><lpage>1942</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2014.08.028</pub-id><pub-id pub-id-type="pmid">25242319</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hutzell</surname><given-names>PA</given-names></name><name><surname>Krusberg</surname><given-names>LR</given-names></name></person-group><year iso-8601-date="1982">1982</year><article-title>Fatty acid compositions of <italic>Caenorhabditis elegans</italic> and <italic>C. Briggsae</italic></article-title><source>Comparative Biochemistry and Physiology Part B</source><volume>73</volume><fpage>517</fpage><lpage>520</lpage><pub-id pub-id-type="doi">10.1016/0305-0491(82)90068-2</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hwang</surname><given-names>AB</given-names></name><name><surname>Ryu</surname><given-names>EA</given-names></name><name><surname>Artan</surname><given-names>M</given-names></name><name><surname>Chang</surname><given-names>HW</given-names></name><name><surname>Kabir</surname><given-names>MH</given-names></name><name><surname>Nam</surname><given-names>HJ</given-names></name><name><surname>Lee</surname><given-names>D</given-names></name><name><surname>Yang</surname><given-names>JS</given-names></name><name><surname>Kim</surname><given-names>S</given-names></name><name><surname>Mair</surname><given-names>WB</given-names></name><name><surname>Lee</surname><given-names>C</given-names></name><name><surname>Lee</surname><given-names>SS</given-names></name><name><surname>Lee</surname><given-names>SJ</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Feedback regulation via AMPK and HIF-1 mediates ROS-dependent longevity in <italic>Caenorhabditis elegans</italic></article-title><source>PNAS</source><volume>111</volume><fpage>E4458</fpage><lpage>E4467</lpage><pub-id pub-id-type="doi">10.1073/pnas.1411199111</pub-id><pub-id pub-id-type="pmid">25288734</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ichi</surname><given-names>I</given-names></name><name><surname>Kono</surname><given-names>N</given-names></name><name><surname>Arita</surname><given-names>Y</given-names></name><name><surname>Haga</surname><given-names>S</given-names></name><name><surname>Arisawa</surname><given-names>K</given-names></name><name><surname>Yamano</surname><given-names>M</given-names></name><name><surname>Nagase</surname><given-names>M</given-names></name><name><surname>Fujiwara</surname><given-names>Y</given-names></name><name><surname>Arai</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Identification of genes and pathways involved in the synthesis of Mead acid (20:3n-9), an indicator of essential fatty acid deficiency</article-title><source>Biochimica et Biophysica Acta</source><volume>1841</volume><fpage>204</fpage><lpage>213</lpage><pub-id pub-id-type="doi">10.1016/j.bbalip.2013.10.013</pub-id><pub-id pub-id-type="pmid">24184513</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>James</surname><given-names>MJ</given-names></name><name><surname>Gibson</surname><given-names>RA</given-names></name><name><surname>Cleland</surname><given-names>LG</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Dietary polyunsaturated fatty acids and inflammatory mediator production</article-title><source>The American Journal of Clinical Nutrition</source><volume>71</volume><fpage>343S</fpage><lpage>348S</lpage><pub-id pub-id-type="doi">10.1093/ajcn/71.1.343S</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>James</surname><given-names>SA</given-names></name><name><surname>Roberts</surname><given-names>BR</given-names></name><name><surname>Hare</surname><given-names>DJ</given-names></name><name><surname>de Jonge</surname><given-names>MD</given-names></name><name><surname>Birchall</surname><given-names>IE</given-names></name><name><surname>Jenkins</surname><given-names>NL</given-names></name><name><surname>Cherny</surname><given-names>RA</given-names></name><name><surname>Bush</surname><given-names>AI</given-names></name><name><surname>McColl</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Direct in vivo imaging of ferrous iron dyshomeostasis in ageing <italic>Caenorhabditis elegans</italic></article-title><source>Chemical Science</source><volume>6</volume><fpage>2952</fpage><lpage>2962</lpage><pub-id pub-id-type="doi">10.1039/C5SC00233H</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jenkins</surname><given-names>NL</given-names></name><name><surname>James</surname><given-names>SA</given-names></name><name><surname>Salim</surname><given-names>A</given-names></name><name><surname>Sumardy</surname><given-names>F</given-names></name><name><surname>Speed</surname><given-names>TP</given-names></name><name><surname>Conrad</surname><given-names>M</given-names></name><name><surname>Richardson</surname><given-names>DR</given-names></name><name><surname>Bush</surname><given-names>AI</given-names></name><name><surname>McColl</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Changes in ferrous iron and glutathione promote ferroptosis and frailty in aging <italic>Caenorhabditis elegans</italic></article-title><source>eLife</source><volume>9</volume><elocation-id>56580</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.56580</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname><given-names>B</given-names></name><name><surname>Ren</surname><given-names>C</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Lu</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>W</given-names></name><name><surname>Wu</surname><given-names>Y</given-names></name><name><surname>Gao</surname><given-names>Y</given-names></name><name><surname>Ratcliffe</surname><given-names>PJ</given-names></name><name><surname>Liu</surname><given-names>H</given-names></name><name><surname>Zhang</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Sodium sulfite is a potential hypoxia inducer that mimics hypoxic stress in <italic>Caenorhabditis elegans</italic></article-title><source>Journal of Biological Inorganic Chemistry</source><volume>16</volume><fpage>267</fpage><lpage>274</lpage><pub-id pub-id-type="doi">10.1007/s00775-010-0723-1</pub-id><pub-id pub-id-type="pmid">21057967</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jung</surname><given-names>HR</given-names></name><name><surname>Sylvänne</surname><given-names>T</given-names></name><name><surname>Koistinen</surname><given-names>KM</given-names></name><name><surname>Tarasov</surname><given-names>K</given-names></name><name><surname>Kauhanen</surname><given-names>D</given-names></name><name><surname>Ekroos</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>High throughput quantitative molecular lipidomics</article-title><source>Biochimica et Biophysica Acta</source><volume>1811</volume><fpage>925</fpage><lpage>934</lpage><pub-id pub-id-type="doi">10.1016/j.bbalip.2011.06.025</pub-id><pub-id pub-id-type="pmid">21767661</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kahn-Kirby</surname><given-names>AH</given-names></name><name><surname>Dantzker</surname><given-names>JLM</given-names></name><name><surname>Apicella</surname><given-names>AJ</given-names></name><name><surname>Schafer</surname><given-names>WR</given-names></name><name><surname>Browse</surname><given-names>J</given-names></name><name><surname>Bargmann</surname><given-names>CI</given-names></name><name><surname>Watts</surname><given-names>JL</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Specific polyunsaturated fatty acids drive TRPV-dependent sensory signaling in vivo</article-title><source>Cell</source><volume>119</volume><fpage>889</fpage><lpage>900</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2004.11.005</pub-id><pub-id pub-id-type="pmid">15607983</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>YI</given-names></name><name><surname>Cho</surname><given-names>JH</given-names></name><name><surname>Yoo</surname><given-names>OJ</given-names></name><name><surname>Ahnn</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Transcriptional regulation and life-span modulation of cytosolic aconitase and ferritin genes in <italic>C. elegans</italic></article-title><source>Journal of Molecular Biology</source><volume>342</volume><fpage>421</fpage><lpage>433</lpage><pub-id pub-id-type="doi">10.1016/j.jmb.2004.07.036</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kosel</surname><given-names>M</given-names></name><name><surname>Wild</surname><given-names>W</given-names></name><name><surname>Bell</surname><given-names>A</given-names></name><name><surname>Rothe</surname><given-names>M</given-names></name><name><surname>Lindschau</surname><given-names>C</given-names></name><name><surname>Steinberg</surname><given-names>CEW</given-names></name><name><surname>Schunck</surname><given-names>WH</given-names></name><name><surname>Menzel</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Eicosanoid formation by a cytochrome P450 isoform expressed in the pharynx of <italic>Caenorhabditis elegans</italic></article-title><source>The Biochemical Journal</source><volume>435</volume><fpage>689</fpage><lpage>700</lpage><pub-id pub-id-type="doi">10.1042/BJ20101942</pub-id><pub-id pub-id-type="pmid">21309752</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kulas</surname><given-names>J</given-names></name><name><surname>Schmidt</surname><given-names>C</given-names></name><name><surname>Rothe</surname><given-names>M</given-names></name><name><surname>Schunck</surname><given-names>WH</given-names></name><name><surname>Menzel</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Cytochrome P450-dependent metabolism of eicosapentaenoic acid in the nematode <italic>Caenorhabditis elegans</italic></article-title><source>Archives of Biochemistry and Biophysics</source><volume>472</volume><fpage>65</fpage><lpage>75</lpage><pub-id pub-id-type="doi">10.1016/j.abb.2008.02.002</pub-id><pub-id pub-id-type="pmid">18282462</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>JY</given-names></name><name><surname>Nam</surname><given-names>M</given-names></name><name><surname>Son</surname><given-names>HY</given-names></name><name><surname>Hyun</surname><given-names>K</given-names></name><name><surname>Jang</surname><given-names>SY</given-names></name><name><surname>Kim</surname><given-names>JW</given-names></name><name><surname>Kim</surname><given-names>MW</given-names></name><name><surname>Jung</surname><given-names>Y</given-names></name><name><surname>Jang</surname><given-names>E</given-names></name><name><surname>Yoon</surname><given-names>SJ</given-names></name><name><surname>Kim</surname><given-names>J</given-names></name><name><surname>Kim</surname><given-names>J</given-names></name><name><surname>Seo</surname><given-names>J</given-names></name><name><surname>Min</surname><given-names>JK</given-names></name><name><surname>Oh</surname><given-names>KJ</given-names></name><name><surname>Han</surname><given-names>BS</given-names></name><name><surname>Kim</surname><given-names>WK</given-names></name><name><surname>Bae</surname><given-names>KH</given-names></name><name><surname>Song</surname><given-names>J</given-names></name><name><surname>Kim</surname><given-names>J</given-names></name><name><surname>Huh</surname><given-names>YM</given-names></name><name><surname>Hwang</surname><given-names>GS</given-names></name><name><surname>Lee</surname><given-names>EW</given-names></name><name><surname>Lee</surname><given-names>SC</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Polyunsaturated fatty acid biosynthesis pathway determines ferroptosis sensitivity in gastric cancer</article-title><source>PNAS</source><volume>117</volume><fpage>32433</fpage><lpage>32442</lpage><pub-id pub-id-type="doi">10.1073/pnas.2006828117</pub-id><pub-id pub-id-type="pmid">33288688</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lesa</surname><given-names>GM</given-names></name><name><surname>Palfreyman</surname><given-names>M</given-names></name><name><surname>Hall</surname><given-names>DH</given-names></name><name><surname>Clandinin</surname><given-names>MT</given-names></name><name><surname>Rudolph</surname><given-names>C</given-names></name><name><surname>Jorgensen</surname><given-names>EM</given-names></name><name><surname>Schiavo</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Long chain polyunsaturated fatty acids are required for efficient neurotransmission in <italic>C. elegans</italic></article-title><source>Journal of Cell Science</source><volume>116</volume><fpage>4965</fpage><lpage>4975</lpage><pub-id pub-id-type="doi">10.1242/jcs.00918</pub-id><pub-id pub-id-type="pmid">14625390</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Libina</surname><given-names>N</given-names></name><name><surname>Berman</surname><given-names>JR</given-names></name><name><surname>Kenyon</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Tissue-specific activities of <italic>C. elegans</italic> DAF-16 in the regulation of lifespan</article-title><source>Cell</source><volume>115</volume><fpage>489</fpage><lpage>502</lpage><pub-id pub-id-type="doi">10.1016/S0092-8674(03)00889-4</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>R</given-names></name><name><surname>Chen</surname><given-names>L</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>G</given-names></name><name><surname>Cheng</surname><given-names>Y</given-names></name><name><surname>Feng</surname><given-names>Z</given-names></name><name><surname>Bai</surname><given-names>X</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>High ratio of ω-3/ω-6 polyunsaturated fatty acids targets mTORC1 to prevent high-fat diet-induced metabolic syndrome and mitochondrial dysfunction in mice</article-title><source>The Journal of Nutritional Biochemistry</source><volume>79</volume><elocation-id>108330</elocation-id><pub-id pub-id-type="doi">10.1016/j.jnutbio.2019.108330</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Löfgren</surname><given-names>L</given-names></name><name><surname>Forsberg</surname><given-names>GB</given-names></name><name><surname>Ståhlman</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>The BUME method: a new rapid and simple chloroform-free method for total lipid extraction of animal tissue</article-title><source>Scientific Reports</source><volume>6</volume><elocation-id>27688</elocation-id><pub-id pub-id-type="doi">10.1038/srep27688</pub-id><pub-id pub-id-type="pmid">27282822</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marza</surname><given-names>E</given-names></name><name><surname>Lesa</surname><given-names>GM</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Polyunsaturated fatty acids and neurotransmission in <italic>Caenorhabditis elegans</italic></article-title><source>Biochemical Society Transactions</source><volume>34</volume><fpage>77</fpage><lpage>80</lpage><pub-id pub-id-type="doi">10.1042/BST0340077</pub-id><pub-id pub-id-type="pmid">16417487</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McKenna</surname><given-names>A</given-names></name><name><surname>Hanna</surname><given-names>M</given-names></name><name><surname>Banks</surname><given-names>E</given-names></name><name><surname>Sivachenko</surname><given-names>A</given-names></name><name><surname>Cibulskis</surname><given-names>K</given-names></name><name><surname>Kernytsky</surname><given-names>A</given-names></name><name><surname>Garimella</surname><given-names>K</given-names></name><name><surname>Altshuler</surname><given-names>D</given-names></name><name><surname>Gabriel</surname><given-names>S</given-names></name><name><surname>Daly</surname><given-names>M</given-names></name><name><surname>DePristo</surname><given-names>MA</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data</article-title><source>Genome Research</source><volume>20</volume><fpage>1297</fpage><lpage>1303</lpage><pub-id pub-id-type="doi">10.1101/gr.107524.110</pub-id><pub-id pub-id-type="pmid">20644199</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mokoena</surname><given-names>NZ</given-names></name><name><surname>Sebolai</surname><given-names>OM</given-names></name><name><surname>Albertyn</surname><given-names>J</given-names></name><name><surname>Pohl</surname><given-names>CH</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Synthesis and function of fatty acids and oxylipins, with a focus on <italic>Caenorhabditis elegans</italic></article-title><source>Prostaglandins &amp; Other Lipid Mediators</source><volume>148</volume><elocation-id>106426</elocation-id><pub-id pub-id-type="doi">10.1016/j.prostaglandins.2020.106426</pub-id><pub-id pub-id-type="pmid">32032704</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mubarak</surname><given-names>SSM</given-names></name><name><surname>Malcolm</surname><given-names>TR</given-names></name><name><surname>Brown</surname><given-names>HG</given-names></name><name><surname>Hanssen</surname><given-names>E</given-names></name><name><surname>Maher</surname><given-names>MJ</given-names></name><name><surname>McColl</surname><given-names>G</given-names></name><name><surname>Jameson</surname><given-names>GNL</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>Biochemical characterization of <italic>Caenorhabditis elegans Ferritins</italic></article-title><source>Biochemistry</source><volume>62</volume><fpage>1484</fpage><lpage>1496</lpage><pub-id pub-id-type="doi">10.1021/acs.biochem.3c00005</pub-id><pub-id pub-id-type="pmid">37014173</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murff</surname><given-names>HJ</given-names></name><name><surname>Edwards</surname><given-names>TL</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Endogenous production of long-chain polyunsaturated fatty acids and metabolic disease risk</article-title><source>Current Cardiovascular Risk Reports</source><volume>8</volume><fpage>1</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1007/S12170-014-0418-1/FULLTEXT.HTML</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakamura</surname><given-names>MT</given-names></name><name><surname>Nara</surname><given-names>TY</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Structure, function, and dietary regulation of delta6, delta5, and delta9 desaturases</article-title><source>Annual Review of Nutrition</source><volume>24</volume><fpage>345</fpage><lpage>376</lpage><pub-id pub-id-type="doi">10.1146/annurev.nutr.24.121803.063211</pub-id><pub-id pub-id-type="pmid">15189125</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O’Rourke</surname><given-names>EJ</given-names></name><name><surname>Kuballa</surname><given-names>P</given-names></name><name><surname>Xavier</surname><given-names>R</given-names></name><name><surname>Ruvkun</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>ω-6 Polyunsaturated fatty acids extend life span through the activation of autophagy</article-title><source>Genes &amp; Development</source><volume>27</volume><elocation-id>205294</elocation-id><pub-id pub-id-type="doi">10.1101/GAD.205294.112</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Padmanabha</surname><given-names>D</given-names></name><name><surname>Padilla</surname><given-names>PA</given-names></name><name><surname>You</surname><given-names>YJ</given-names></name><name><surname>Baker</surname><given-names>KD</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>A HIF-independent mediator of transcriptional responses to oxygen deprivation in <italic>Caenorhabditis elegans</italic></article-title><source>Genetics</source><volume>199</volume><fpage>739</fpage><lpage>748</lpage><pub-id pub-id-type="doi">10.1534/GENETICS.114.173989/-/DC1</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Papandreou</surname><given-names>I</given-names></name><name><surname>Cairns</surname><given-names>RA</given-names></name><name><surname>Fontana</surname><given-names>L</given-names></name><name><surname>Lim</surname><given-names>AL</given-names></name><name><surname>Denko</surname><given-names>NC</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption</article-title><source>Cell Metabolism</source><volume>3</volume><fpage>187</fpage><lpage>197</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2006.01.012</pub-id><pub-id pub-id-type="pmid">16517406</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pekec</surname><given-names>T</given-names></name><name><surname>Lewandowski</surname><given-names>J</given-names></name><name><surname>Komur</surname><given-names>AA</given-names></name><name><surname>Sobańska</surname><given-names>D</given-names></name><name><surname>Guo</surname><given-names>Y</given-names></name><name><surname>Świtońska-Kurkowska</surname><given-names>K</given-names></name><name><surname>Małecki</surname><given-names>JM</given-names></name><name><surname>Dubey</surname><given-names>AA</given-names></name><name><surname>Pokrzywa</surname><given-names>W</given-names></name><name><surname>Frankowski</surname><given-names>M</given-names></name><name><surname>Figiel</surname><given-names>M</given-names></name><name><surname>Ciosk</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Ferritin-mediated iron detoxification promotes hypothermia survival in <italic>Caenorhabditis elegans</italic> and murine neurons</article-title><source>Nature Communications</source><volume>13</volume><fpage>1</fpage><lpage>19</lpage><pub-id pub-id-type="doi">10.1038/s41467-022-32500-z</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perez</surname><given-names>CL</given-names></name><name><surname>Van Gilst</surname><given-names>MR</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>A 13C Isotope labeling strategy reveals the influence of insulin signaling on lipogenesis in <italic>C. elegans</italic></article-title><source>Cell Metabolism</source><volume>8</volume><fpage>266</fpage><lpage>274</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2008.08.007</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perez</surname><given-names>MA</given-names></name><name><surname>Magtanong</surname><given-names>L</given-names></name><name><surname>Dixon</surname><given-names>SJ</given-names></name><name><surname>Watts</surname><given-names>JL</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Dietary lipids induce ferroptosis in <italic>Caenorhabditis elegans</italic> and human cancer cells</article-title><source>Developmental Cell</source><volume>54</volume><fpage>447</fpage><lpage>454</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2020.06.019</pub-id><pub-id pub-id-type="pmid">32652074</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peyou-Ndi</surname><given-names>MM</given-names></name><name><surname>Watts</surname><given-names>JL</given-names></name><name><surname>Browse</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Identification and characterization of an animal delta(12) fatty acid desaturase gene by heterologous expression in <italic>Saccharomyces cerevisiae</italic></article-title><source>Archives of Biochemistry and Biophysics</source><volume>376</volume><fpage>399</fpage><lpage>408</lpage><pub-id pub-id-type="doi">10.1006/abbi.2000.1733</pub-id><pub-id pub-id-type="pmid">10775428</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Plays</surname><given-names>M</given-names></name><name><surname>Müller</surname><given-names>S</given-names></name><name><surname>Rodriguez</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Chemistry and biology of ferritin</article-title><source>Metallomics</source><volume>13</volume><elocation-id>021</elocation-id><pub-id pub-id-type="doi">10.1093/mtomcs/mfab021</pub-id><pub-id pub-id-type="pmid">33881539</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rauthan</surname><given-names>M</given-names></name><name><surname>Ranji</surname><given-names>P</given-names></name><name><surname>Aguilera Pradenas</surname><given-names>N</given-names></name><name><surname>Pitot</surname><given-names>C</given-names></name><name><surname>Pilon</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>The mitochondrial unfolded protein response activator ATFS-1 protects cells from inhibition of the mevalonate pathway</article-title><source>PNAS</source><volume>110</volume><fpage>5981</fpage><lpage>5986</lpage><pub-id pub-id-type="doi">10.1073/pnas.1218778110</pub-id><pub-id pub-id-type="pmid">23530189</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Romero</surname><given-names>AL</given-names></name><name><surname>Zelmanovich</surname><given-names>V</given-names></name><name><surname>Abergel</surname><given-names>Z</given-names></name><name><surname>Zuckerman</surname><given-names>B</given-names></name><name><surname>Shaked</surname><given-names>M</given-names></name><name><surname>Abergel</surname><given-names>R</given-names></name><name><surname>Livshits</surname><given-names>L</given-names></name><name><surname>Smith</surname><given-names>Y</given-names></name><name><surname>Gross</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Ferritin is regulated by a neuro-intestinal axis in the nematode <italic>Caenorhabditis elegans</italic></article-title><source>Redox Biology</source><volume>28</volume><elocation-id>101359</elocation-id><pub-id pub-id-type="doi">10.1016/j.redox.2019.101359</pub-id><pub-id pub-id-type="pmid">31677552</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Romney</surname><given-names>SJ</given-names></name><name><surname>Thacker</surname><given-names>C</given-names></name><name><surname>Leibold</surname><given-names>EA</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>An iron enhancer element in the FTN-1 gene directs iron-dependent expression in <italic>Caenorhabditis elegans</italic> intestine</article-title><source>The Journal of Biological Chemistry</source><volume>283</volume><fpage>716</fpage><lpage>725</lpage><pub-id pub-id-type="doi">10.1074/jbc.M707043200</pub-id><pub-id pub-id-type="pmid">18024960</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Romney</surname><given-names>SJ</given-names></name><name><surname>Newman</surname><given-names>BS</given-names></name><name><surname>Thacker</surname><given-names>C</given-names></name><name><surname>Leibold</surname><given-names>EA</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>HIF-1 regulates iron homeostasis in <italic>Caenorhabditis elegans</italic> by activation and inhibition of genes involved in iron uptake and storage</article-title><source>PLOS Genetics</source><volume>7</volume><elocation-id>e1002394</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1002394</pub-id><pub-id pub-id-type="pmid">22194696</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ruiz</surname><given-names>M</given-names></name><name><surname>Bodhicharla</surname><given-names>R</given-names></name><name><surname>Svensk</surname><given-names>E</given-names></name><name><surname>Devkota</surname><given-names>R</given-names></name><name><surname>Busayavalasa</surname><given-names>K</given-names></name><name><surname>Palmgren</surname><given-names>H</given-names></name><name><surname>Ståhlman</surname><given-names>M</given-names></name><name><surname>Boren</surname><given-names>J</given-names></name><name><surname>Pilon</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Membrane fluidity is regulated by the <italic>C. elegans</italic> transmembrane protein FLD-1 and its human homologs TLCD1/2</article-title><source>eLife</source><volume>7</volume><elocation-id>e40686</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.40686</pub-id><pub-id pub-id-type="pmid">30509349</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ruiz</surname><given-names>M</given-names></name><name><surname>Bodhicharla</surname><given-names>R</given-names></name><name><surname>Ståhlman</surname><given-names>M</given-names></name><name><surname>Svensk</surname><given-names>E</given-names></name><name><surname>Busayavalasa</surname><given-names>K</given-names></name><name><surname>Palmgren</surname><given-names>H</given-names></name><name><surname>Ruhanen</surname><given-names>H</given-names></name><name><surname>Boren</surname><given-names>J</given-names></name><name><surname>Pilon</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Evolutionarily conserved long-chain Acyl-CoA synthetases regulate membrane composition and fluidity</article-title><source>eLife</source><volume>8</volume><elocation-id>e47733</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.47733</pub-id><pub-id pub-id-type="pmid">31769755</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ruiz</surname><given-names>M</given-names></name><name><surname>Devkota</surname><given-names>R</given-names></name><name><surname>Kaper</surname><given-names>D</given-names></name><name><surname>Ruhanen</surname><given-names>H</given-names></name><name><surname>Busayavalasa</surname><given-names>K</given-names></name><name><surname>Radović</surname><given-names>U</given-names></name><name><surname>Henricsson</surname><given-names>M</given-names></name><name><surname>Käkelä</surname><given-names>R</given-names></name><name><surname>Borén</surname><given-names>J</given-names></name><name><surname>Pilon</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>AdipoR2 recruits protein interactors to promote fatty acid elongation and membrane fluidity</article-title><source>The Journal of Biological Chemistry</source><volume>299</volume><elocation-id>104799</elocation-id><pub-id pub-id-type="doi">10.1016/j.jbc.2023.104799</pub-id><pub-id pub-id-type="pmid">37164154</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shao</surname><given-names>Z</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Powell-Coffman</surname><given-names>JA</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Two distinct roles for EGL-9 in the regulation of HIF-1-mediated gene expression in <italic>Caenorhabditis elegans</italic></article-title><source>Genetics</source><volume>183</volume><fpage>821</fpage><lpage>829</lpage><pub-id pub-id-type="doi">10.1534/genetics.109.107284</pub-id><pub-id pub-id-type="pmid">19737748</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shen</surname><given-names>J</given-names></name><name><surname>Wu</surname><given-names>G</given-names></name><name><surname>Tsai</surname><given-names>AL</given-names></name><name><surname>Zhou</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Structure and mechanism of a unique diiron center in mammalian stearoyl-CoA desaturase</article-title><source>Journal of Molecular Biology</source><volume>432</volume><fpage>5152</fpage><lpage>5161</lpage><pub-id pub-id-type="doi">10.1016/j.jmb.2020.05.017</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shen</surname><given-names>J</given-names></name><name><surname>Wu</surname><given-names>G</given-names></name><name><surname>Pierce</surname><given-names>BS</given-names></name><name><surname>Tsai</surname><given-names>AL</given-names></name><name><surname>Zhou</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>Free ferrous ions sustain activity of mammalian stearoyl-CoA desaturase-1</article-title><source>The Journal of Biological Chemistry</source><volume>299</volume><elocation-id>104897</elocation-id><pub-id pub-id-type="doi">10.1016/j.jbc.2023.104897</pub-id><pub-id pub-id-type="pmid">37290533</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sherratt</surname><given-names>SCR</given-names></name><name><surname>Juliano</surname><given-names>RA</given-names></name><name><surname>Copland</surname><given-names>C</given-names></name><name><surname>Bhatt</surname><given-names>DL</given-names></name><name><surname>Libby</surname><given-names>P</given-names></name><name><surname>Mason</surname><given-names>RP</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>EPA and DHA containing phospholipids have contrasting effects on membrane structure</article-title><source>Journal of Lipid Research</source><volume>62</volume><elocation-id>100106</elocation-id><pub-id pub-id-type="doi">10.1016/j.jlr.2021.100106</pub-id><pub-id pub-id-type="pmid">34400132</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Simopoulos</surname><given-names>AP</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Essential fatty acids in health and chronic disease</article-title><source>The American Journal of Clinical Nutrition</source><volume>70</volume><fpage>560s</fpage><lpage>569s</lpage><pub-id pub-id-type="doi">10.1093/AJCN/70.3.560S</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sperling</surname><given-names>P</given-names></name><name><surname>Ternes</surname><given-names>P</given-names></name><name><surname>Zank</surname><given-names>TK</given-names></name><name><surname>Heinz</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>The evolution of desaturases</article-title><source>Prostaglandins, Leukotrienes and Essential Fatty Acids</source><volume>68</volume><fpage>73</fpage><lpage>95</lpage><pub-id pub-id-type="doi">10.1016/S0952-3278(02)00258-2</pub-id></element-citation></ref><ref id="bib75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stanley</surname><given-names>WC</given-names></name><name><surname>Khairallah</surname><given-names>RJ</given-names></name><name><surname>Dabkowski</surname><given-names>ER</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Update on lipids and mitochondrial function: impact of dietary n-3 polyunsaturated fatty acids</article-title><source>Current Opinion in Clinical Nutrition and Metabolic Care</source><volume>15</volume><fpage>122</fpage><lpage>126</lpage><pub-id pub-id-type="doi">10.1097/MCO.0B013E32834FDAF7</pub-id></element-citation></ref><ref id="bib76"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Sulston</surname><given-names>J</given-names></name><name><surname>Hodgkin</surname><given-names>J</given-names></name></person-group><year iso-8601-date="1988">1988</year><source>The Nematode Caenorhabditis Elegans</source><publisher-name>Cold Spring Harbor Laboratory Press</publisher-name></element-citation></ref><ref id="bib77"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Svensk</surname><given-names>E</given-names></name><name><surname>Ståhlman</surname><given-names>M</given-names></name><name><surname>Andersson</surname><given-names>CH</given-names></name><name><surname>Johansson</surname><given-names>M</given-names></name><name><surname>Borén</surname><given-names>J</given-names></name><name><surname>Pilon</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>PAQR-2 regulates fatty acid desaturation during cold adaptation in <italic>C. elegans</italic></article-title><source>PLOS Genetics</source><volume>9</volume><elocation-id>e1003801</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1003801</pub-id><pub-id pub-id-type="pmid">24068966</pub-id></element-citation></ref><ref id="bib78"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Svensk</surname><given-names>E</given-names></name><name><surname>Devkota</surname><given-names>R</given-names></name><name><surname>Ståhlman</surname><given-names>M</given-names></name><name><surname>Ranji</surname><given-names>P</given-names></name><name><surname>Rauthan</surname><given-names>M</given-names></name><name><surname>Magnusson</surname><given-names>F</given-names></name><name><surname>Hammarsten</surname><given-names>S</given-names></name><name><surname>Johansson</surname><given-names>M</given-names></name><name><surname>Borén</surname><given-names>J</given-names></name><name><surname>Pilon</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title><italic>Caenorhabditis elegans</italic> PAQR-2 and IGLR-2 protect against glucose toxicity by modulating membrane lipid composition</article-title><source>PLOS Genetics</source><volume>12</volume><elocation-id>e1005982</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1005982</pub-id><pub-id pub-id-type="pmid">27082444</pub-id></element-citation></ref><ref id="bib79"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tanaka</surname><given-names>T</given-names></name><name><surname>Ikita</surname><given-names>K</given-names></name><name><surname>Ashida</surname><given-names>T</given-names></name><name><surname>Motoyama</surname><given-names>Y</given-names></name><name><surname>Yamaguchi</surname><given-names>Y</given-names></name><name><surname>Satouchi</surname><given-names>K</given-names></name></person-group><year iso-8601-date="1996">1996</year><article-title>Effects of growth temperature on the fatty acid composition of the free-living nematode <italic>Caenorhabditis elegans</italic></article-title><source>Lipids</source><volume>31</volume><fpage>1173</fpage><lpage>1178</lpage><pub-id pub-id-type="doi">10.1007/BF02524292</pub-id><pub-id pub-id-type="pmid">8934450</pub-id></element-citation></ref><ref id="bib80"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tanaka</surname><given-names>T</given-names></name><name><surname>Izuwa</surname><given-names>S</given-names></name><name><surname>Tanaka</surname><given-names>K</given-names></name><name><surname>Yamamoto</surname><given-names>D</given-names></name><name><surname>Takimoto</surname><given-names>T</given-names></name><name><surname>Matsuura</surname><given-names>F</given-names></name><name><surname>Satouchi</surname><given-names>K</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Biosynthesis of 1,2-dieicosapentaenoyl-sn-glycero-3-phosphocholine in <italic>Caenorhabditis elegans</italic></article-title><source>European Journal of Biochemistry</source><volume>263</volume><fpage>189</fpage><lpage>195</lpage><pub-id pub-id-type="doi">10.1046/j.1432-1327.1999.00480.x</pub-id><pub-id pub-id-type="pmid">10429203</pub-id></element-citation></ref><ref id="bib81"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Valentini</surname><given-names>S</given-names></name><name><surname>Cabreiro</surname><given-names>F</given-names></name><name><surname>Ackerman</surname><given-names>D</given-names></name><name><surname>Alam</surname><given-names>MM</given-names></name><name><surname>Kunze</surname><given-names>MBA</given-names></name><name><surname>Kay</surname><given-names>CWM</given-names></name><name><surname>Gems</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Manipulation of in vivo iron levels can alter resistance to oxidative stress without affecting ageing in the nematode <italic>C. elegans</italic></article-title><source>Mechanisms of Ageing and Development</source><volume>133</volume><fpage>282</fpage><lpage>290</lpage><pub-id pub-id-type="doi">10.1016/j.mad.2012.03.003</pub-id><pub-id pub-id-type="pmid">22445852</pub-id></element-citation></ref><ref id="bib82"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vásquez</surname><given-names>V</given-names></name><name><surname>Krieg</surname><given-names>M</given-names></name><name><surname>Lockhead</surname><given-names>D</given-names></name><name><surname>Goodman</surname><given-names>MB</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Phospholipids that contain polyunsaturated fatty acids enhance neuronal cell mechanics and touch sensation</article-title><source>Cell Reports</source><volume>6</volume><fpage>70</fpage><lpage>80</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2013.12.012</pub-id></element-citation></ref><ref id="bib83"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vrablik</surname><given-names>TL</given-names></name><name><surname>Watts</surname><given-names>JL</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Polyunsaturated fatty acid derived signaling in reproduction and development: insights from <italic>Caenorhabditis elegans</italic> and <italic>Drosophila melanogaster</italic></article-title><source>Molecular Reproduction and Development</source><volume>80</volume><fpage>244</fpage><lpage>259</lpage><pub-id pub-id-type="doi">10.1002/MRD.22167</pub-id></element-citation></ref><ref id="bib84"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>C</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Xu</surname><given-names>X</given-names></name><name><surname>Fu</surname><given-names>L</given-names></name><name><surname>Xu</surname><given-names>J</given-names></name><name><surname>Zhu</surname><given-names>H</given-names></name><name><surname>Hu</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>C</given-names></name><name><surname>Wang</surname><given-names>M</given-names></name><name><surname>Wu</surname><given-names>Y</given-names></name><name><surname>Zou</surname><given-names>X</given-names></name><name><surname>Liang</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Polyunsaturated fatty acids promote the rapid fusion of lipid droplets in <italic>Caenorhabditis elegans</italic></article-title><source>Journal of Biological Chemistry</source><volume>298</volume><elocation-id>102179</elocation-id><pub-id pub-id-type="doi">10.1016/j.jbc.2022.102179</pub-id></element-citation></ref><ref id="bib85"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Watts</surname><given-names>JL</given-names></name><name><surname>Browse</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Genetic dissection of polyunsaturated fatty acid synthesis in <italic>Caenorhabditis elegans</italic></article-title><source>PNAS</source><volume>99</volume><fpage>5854</fpage><lpage>5859</lpage><pub-id pub-id-type="doi">10.1073/pnas.092064799</pub-id><pub-id pub-id-type="pmid">11972048</pub-id></element-citation></ref><ref id="bib86"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Worgall</surname><given-names>TS</given-names></name><name><surname>Sturley</surname><given-names>SL</given-names></name><name><surname>Seo</surname><given-names>T</given-names></name><name><surname>Osborne</surname><given-names>TF</given-names></name><name><surname>Deckelbaum</surname><given-names>RJ</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>Polyunsaturated fatty acids decrease expression of promoters with sterol regulatory elements by decreasing levels of mature sterol regulatory element-binding protein</article-title><source>The Journal of Biological Chemistry</source><volume>273</volume><fpage>25537</fpage><lpage>25540</lpage><pub-id pub-id-type="doi">10.1074/JBC.273.40.25537</pub-id><pub-id pub-id-type="pmid">9748213</pub-id></element-citation></ref><ref id="bib87"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Jiao</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2024">2024</year><article-title>The relationship between n-3 polyunsaturated fatty acids and telomere: A review on proposed nutritional treatment against metabolic syndrome and potential signaling pathways</article-title><source>Critical Reviews in Food Science and Nutrition</source><volume>64</volume><fpage>4457</fpage><lpage>4476</lpage><pub-id pub-id-type="doi">10.1080/10408398.2022.2142196</pub-id></element-citation></ref><ref id="bib88"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xie</surname><given-names>M</given-names></name><name><surname>Roy</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Increased levels of hydrogen peroxide induce a HIF-1-dependent modification of lipid metabolism in AMPK compromised <italic>C. elegans</italic> dauer larvae</article-title><source>Cell Metabolism</source><volume>16</volume><fpage>322</fpage><lpage>335</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2012.07.016</pub-id><pub-id pub-id-type="pmid">22921415</pub-id></element-citation></ref><ref id="bib89"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yahagi</surname><given-names>N</given-names></name><name><surname>Shimano</surname><given-names>H</given-names></name><name><surname>Hasty</surname><given-names>AH</given-names></name><name><surname>Amemiya-Kudo</surname><given-names>M</given-names></name><name><surname>Okazaki</surname><given-names>H</given-names></name><name><surname>Tamura</surname><given-names>Y</given-names></name><name><surname>Iizuka</surname><given-names>Y</given-names></name><name><surname>Shionoiri</surname><given-names>F</given-names></name><name><surname>Ohashi</surname><given-names>K</given-names></name><name><surname>Osuga</surname><given-names>J</given-names></name><name><surname>Harada</surname><given-names>K</given-names></name><name><surname>Gotoda</surname><given-names>T</given-names></name><name><surname>Nagai</surname><given-names>R</given-names></name><name><surname>Ishibashi</surname><given-names>S</given-names></name><name><surname>Yamada</surname><given-names>N</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>A crucial role of sterol regulatory element-binding Protein-1 in the regulation of lipogenic gene expression by polyunsaturated fatty acids</article-title><source>Journal of Biological Chemistry</source><volume>274</volume><fpage>35840</fpage><lpage>35844</lpage><pub-id pub-id-type="doi">10.1074/jbc.274.50.35840</pub-id></element-citation></ref><ref id="bib90"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>WS</given-names></name><name><surname>Kim</surname><given-names>KJ</given-names></name><name><surname>Gaschler</surname><given-names>MM</given-names></name><name><surname>Patel</surname><given-names>M</given-names></name><name><surname>Shchepinov</surname><given-names>MS</given-names></name><name><surname>Stockwell</surname><given-names>BR</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Peroxidation of polyunsaturated fatty acids by lipoxygenases drives ferroptosis</article-title><source>PNAS</source><volume>113</volume><fpage>E4966</fpage><lpage>E4975</lpage><pub-id pub-id-type="doi">10.1073/pnas.1603244113</pub-id><pub-id pub-id-type="pmid">27506793</pub-id></element-citation></ref><ref id="bib91"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yoneda</surname><given-names>T</given-names></name><name><surname>Benedetti</surname><given-names>C</given-names></name><name><surname>Urano</surname><given-names>F</given-names></name><name><surname>Clark</surname><given-names>SG</given-names></name><name><surname>Harding</surname><given-names>HP</given-names></name><name><surname>Ron</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Compartment-specific perturbation of protein handling activates genes encoding mitochondrial chaperones</article-title><source>Journal of Cell Science</source><volume>117</volume><fpage>4055</fpage><lpage>4066</lpage><pub-id pub-id-type="doi">10.1242/jcs.01275</pub-id><pub-id pub-id-type="pmid">15280428</pub-id></element-citation></ref><ref id="bib92"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>JY</given-names></name><name><surname>Kothapalli</surname><given-names>KSD</given-names></name><name><surname>Brenna</surname><given-names>JT</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Desaturase and elongase-limiting endogenous long-chain polyunsaturated fatty acid biosynthesis</article-title><source>Current Opinion in Clinical Nutrition and Metabolic Care</source><volume>19</volume><fpage>103</fpage><lpage>110</lpage><pub-id pub-id-type="doi">10.1097/MCO.0000000000000254</pub-id><pub-id pub-id-type="pmid">26828581</pub-id></element-citation></ref><ref id="bib93"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>XR</given-names></name><name><surname>Green</surname><given-names>AG</given-names></name><name><surname>Singh</surname><given-names>SP</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title><italic>Caenorhabditis elegans</italic> Delta12-desaturase FAT-2 is a bifunctional desaturase able to desaturate a diverse range of fatty acid substrates at the Delta12 and Delta15 positions</article-title><source>The Journal of Biological Chemistry</source><volume>286</volume><fpage>43644</fpage><lpage>43650</lpage><pub-id pub-id-type="doi">10.1074/jbc.M111.266114</pub-id><pub-id pub-id-type="pmid">22041902</pub-id></element-citation></ref><ref id="bib94"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>XG</given-names></name><name><surname>Nicholson Puthenveedu</surname><given-names>S</given-names></name><name><surname>Shen</surname><given-names>Y</given-names></name><name><surname>La</surname><given-names>K</given-names></name><name><surname>Ozlu</surname><given-names>C</given-names></name><name><surname>Wang</surname><given-names>T</given-names></name><name><surname>Klompstra</surname><given-names>D</given-names></name><name><surname>Gultekin</surname><given-names>Y</given-names></name><name><surname>Chi</surname><given-names>J</given-names></name><name><surname>Fidelin</surname><given-names>J</given-names></name><name><surname>Peng</surname><given-names>T</given-names></name><name><surname>Molina</surname><given-names>H</given-names></name><name><surname>Hang</surname><given-names>HC</given-names></name><name><surname>Min</surname><given-names>W</given-names></name><name><surname>Birsoy</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>CHP1 regulates compartmentalized glycerolipid synthesis by activating GPAT4</article-title><source>Molecular Cell</source><volume>74</volume><fpage>45</fpage><lpage>58</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2019.01.037</pub-id><pub-id pub-id-type="pmid">30846317</pub-id></element-citation></ref></ref-list></back><sub-article article-type="editor-report" id="sa0"><front-stub><article-id pub-id-type="doi">10.7554/eLife.104181.4.sa0</article-id><title-group><article-title>eLife Assessment</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Campelo</surname><given-names>Felix</given-names></name><role specific-use="editor">Reviewing Editor</role><aff><institution>Institute of Photonic Sciences</institution><country>Spain</country></aff></contrib></contrib-group><kwd-group kwd-group-type="evidence-strength"><kwd>Compelling</kwd></kwd-group><kwd-group kwd-group-type="claim-importance"><kwd>Fundamental</kwd></kwd-group></front-stub><body><p>This <bold>fundamental</bold> study investigates the role of polyunsaturated fatty acids (PUFAs) in physiology and membrane biology, using a unique model to perform a thorough genetic screen that demonstrates that PUFA synthesis defects cannot be compensated for by mutations in other pathways. These findings are supported by <bold>compelling</bold> evidence from a high quality genetic screen, functional validation of their hits, and lipid analyses. This study will appeal to researchers in membrane biology, lipid metabolism, and <italic>C. elegans</italic> genetics.</p></body></sub-article><sub-article article-type="referee-report" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.104181.4.sa1</article-id><title-group><article-title>Reviewer #1 (Public review):</article-title></title-group><contrib-group><contrib contrib-type="author"><anonymous/><role specific-use="referee">Reviewer</role></contrib></contrib-group></front-stub><body><p>Summary:</p><p>This study addresses the roles of polyunsaturated fatty acids (PUFAs) in animal physiology and membrane function. A <italic>C. elegans</italic> strain carrying the fat-2(wa17) mutation possesses a very limited ability to synthesize PUFAs and there is no dietary input because the <italic>E. coli</italic> diet consumed by lab grown <italic>C. elegans</italic> does not contain any PUFAs. The fat-2 mutant strain was characterized to confirm that the worms grow slowly, have rigid membranes, and have a constitutive mitochondrial stress response. The authors showed that chemical treatments or mutations known to increase membrane fluidity did not rescue growth defects. A thorough genetic screen was performed to identify genetic changes to compensate for the lack of PUFAs. The newly isolated suppressor mutations that compensated for FAT-2 growth defects included intergenic suppressors in the fat-2 gene, as well as constitutive mutations in the hypoxia sensing pathway components EGL-9 and HIF-1, and loss of function mutations in ftn-2, a gene encoding the iron storage protein ferritin. Taken together, these mutations lead to the model that increased intracellular iron, an essential cofactor for fatty acid desaturases, allows the minimally functional FAT-2(wa17) enzyme to be more active, resulting in increased desaturation and increased PUFA synthesis.</p><p>Strengths:</p><p>(1) This study provides new information further characterizing fat-2 mutants. The authors measured increased rigidity of membranes compared to wild type worms, however this rigidity is not able to be rescued with other fluidity treatments such as detergent or mutants. Rescue was only achieved with polyunsaturated fatty acid supplementation.</p><p>(2) A very thorough genetic suppressor screen was performed. In addition to some internal fat-2 compensatory mutations, the only changes in pathways identified that are capable of compensating for deficient PUFA synthesis was the hypoxia pathway and the iron storage protein ferritin. Suppressor mutations included an egl-9 mutation that constitutively activates HIF-1, and Gain of function mutations in hif-1 that are dominant. This increased activity of HIF conferred by specific egl-9 and hif-1 mutations lead to decreased expression of ftn-2. Indeed, loss of ftn-2 leads to higher intracellular iron. The increased iron apparently makes the FAT-2 fatty acid desaturase enzyme more active, allowing for the production of more PUFAs.</p><p>(3) The mutations isolated in the suppressor screen show that the only mutations able to compensate for lack of PUFAs were ones that increased PUFA synthesis by the defective FAT-2 desaturase, thus demonstrating the essential need for PUFAs that cannot be overcome by changes in other pathways. This is a very novel study, taking advantage of genetic analysis of <italic>C. elegans</italic>, and it confirms the observations in humans that certain essential PUFAs are required for growth and development.</p><p>(4) Overall, the paper is well written, and the experiments were carried out carefully and thoroughly. The conclusions are well supported by the results.</p><p>Weaknesses:</p><p>Overall, there are not many weaknesses. The main one I noticed is that the lipidomic analysis shown in Figs 3C, 7C, S1 and S3. While these data are an essential part of the analysis and provide strong evidence for the conclusions of the study, it is unfortunate that the methods used did not enable the distinction between two 18:1 isomers. These two isomers of 18:1 are important in <italic>C. elegans</italic> biology, because one is a substrate for FAT-2 (18:1n-9, oleic acid) and the other is not (18:1n-7, cis vaccenic acid). Although rarer in mammals, cis-vaccenic acid is the most abundant fatty acid in <italic>C. elegans</italic> and is likely the most important structural MUFA. The measurement of these two isomers is not essential for the conclusions of the study.</p></body></sub-article><sub-article article-type="referee-report" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.104181.4.sa2</article-id><title-group><article-title>Reviewer #2 (Public review):</article-title></title-group><contrib-group><contrib contrib-type="author"><anonymous/><role specific-use="referee">Reviewer</role></contrib></contrib-group></front-stub><body><p>Summary:</p><p>The authors use a genetic screen in <italic>C. elegans</italic> to investigate the physiological roles of polyunsaturated fatty acids (PUFAs). They screen for mutations that rescue fat-2 mutants, which have strong reductions in PUFAs. As a result, either mutations in fat-2 itself or mutations in genes involved in the HIF-1 pathway were found to rescue fat-2 mutants. Mutants in the HIF-1 pathway rescue fat-2 mutants by boosting their catalytic activity (via upregulated Fe2+). Thus, the authors show that in the context of fat-2 mutation, the sole genetic means to rescue PUFA insufficiency is to restore PUFA levels.</p><p>Strengths:</p><p>As <italic>C. elegans</italic> can produce PUFAs de novo as essential lipids, the genetic model is well-suited to study the fundamental roles of PUFAs. The genetic screen finds mutations in convergent pathways, suggesting that it has reached near-saturation. The authors extensively validate the results of the screening and provide sufficient mechanistic insights to show how PUFA levels are restored in HIF-1 pathway mutants. As many of the mutations found to rescue fat-2 mutants are of gain-of-function, it is unlikely that similar discoveries could have been made with other approaches like genome-wide CRISPR screenings, making the current study distinctive. Consequently, the study provides important messages. First, it shows that PUFAs are essential for life. The inability to genetically rescue PUFA deficiency, except for mutations that restore PUFA levels, suggests that they have pleiotropic essential functions. In addition, the results suggest that the most essential functions of PUFAs are not in fluidity regulation, which is consistent with recent reviews proposing that the importance of unsaturation goes beyond fluidity (doi: 10.1016/j.tibs.2023.08.004 and doi: 10.1101/cshperspect.a041409). Thus, the study provides fundamental insights about how membrane lipid composition can be linked to biological functions.</p><p>Weaknesses:</p><p>The authors put in a lot of effort to answer the questions that arose through peer review, and now all the claims seem to be supported by experimental data. Thus, I do not see obvious weaknesses. Of course, it remains unclear what PUFAs do beyond fluidity regulation, but this is something that cannot be answered from a single study.</p></body></sub-article><sub-article article-type="author-comment" id="sa3"><front-stub><article-id pub-id-type="doi">10.7554/eLife.104181.4.sa3</article-id><title-group><article-title>Author response</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Kaper</surname><given-names>Delaney</given-names></name><role specific-use="author">Author</role><aff><institution>University of Gothenburg</institution><addr-line><named-content content-type="city">Gothenburg</named-content></addr-line><country>Sweden</country></aff></contrib><contrib contrib-type="author"><name><surname>Radović</surname><given-names>Uroš</given-names></name><role specific-use="author">Author</role><aff><institution>University of Gothenburg</institution><addr-line><named-content content-type="city">Gothenburg</named-content></addr-line><country>Sweden</country></aff></contrib><contrib contrib-type="author"><name><surname>Bergh</surname><given-names>Per-Olof</given-names></name><role specific-use="author">Author</role><aff><institution>University of Gothenburg</institution><addr-line><named-content content-type="city">Gothenburg</named-content></addr-line><country>Sweden</country></aff></contrib><contrib contrib-type="author"><name><surname>Qvist</surname><given-names>August</given-names></name><role specific-use="author">Author</role><aff><institution>University of Gothenburg</institution><addr-line><named-content content-type="city">Gothenburg</named-content></addr-line><country>Sweden</country></aff></contrib><contrib contrib-type="author"><name><surname>Henricsson</surname><given-names>Marcus</given-names></name><role specific-use="author">Author</role><aff><institution>University of Gothenburg</institution><addr-line><named-content content-type="city">Gothenburg</named-content></addr-line><country>Sweden</country></aff></contrib><contrib contrib-type="author"><name><surname>Borén</surname><given-names>Jan</given-names></name><role specific-use="author">Author</role><aff><institution>University of Gothenburg</institution><addr-line><named-content content-type="city">Gothenburg</named-content></addr-line><country>Sweden</country></aff></contrib><contrib contrib-type="author"><name><surname>Pilon</surname><given-names>Marc</given-names></name><role specific-use="author">Author</role><aff><institution>University of Gothenburg</institution><addr-line><named-content content-type="city">Gothenburg</named-content></addr-line><country>Sweden</country></aff></contrib></contrib-group></front-stub><body><p>The following is the authors’ response to the previous reviews.</p><disp-quote content-type="editor-comment"><p><bold>Reviewer #1:</bold></p><p>The addition of the discussion about the two isomers of 18:1 didn't quite work in the place that the authors added. What the authors wrote on line 126 is true about 18:1 isomers in wild type worms. However, they are reporting their lipidomics results of the fat-2(wa17) mutant worms. In this case, a substantial amount of the 18:1 is the oleic acid (18:1n-9) isomer. The authors can check Table 2 in their reference [10] and see that wild type and other fat mutants indeed contain approximately 10 fold more cis vaccenic than oleic acid, the fat-2(wa17) mutants do accumulate oleic acid, because the wild type activity of FAT-2 is to convert oleic acid to linoleic acid, where it can be converted to downstream PUFAs. I suggest editing their sentence on line 126 to say that the high 18:1 they observed agrees with [10], and then comment about reference 10 showing the majority of 18:1 being the cis-vaccenic isomer in most strains, but the oleic acid isomer is more abundantly in the fat-2(wa17) mutant strain.</p></disp-quote><p>We thank the reviewer for spotting that and sparing us a bit of embarrassment. We have now modified the text and hope we got it right this time:</p><p>&quot;Even though the lipid analysis methods used here are not able to distinguish between different 18:1 species, a previous study showed that the majority of the 18:1 fatty acids in the <italic>fat-2(wa17)</italic> mutant is actually 18:1n9 (OA) [10] and not 18:1n7 (vaccenic acid) as in most other strains [10,23]; this is because OA is the substrate of FAT-2 and thus accumulates in the mutant.&quot;</p><disp-quote content-type="editor-comment"><p><bold>Reviewer #2:</bold></p><p>I still do not agree with the answer to my previous comment 6 regarding Figure S2E. The authors claim that hif-1(et69) suppresses fat-2(wa17) in a ftn-2 null background (in Figure S2 legend for example). To claim so, they would need to compare the triple mutant with fat2(wa17);ftn-2(ok404) and show some rescue. However, we see in Figure 5H that ftn2(ok404) alone rescues fat-2(wa17). Thus, by comparing both figures, I see no additional effect of hif-1(et69) in an ftn-2(ok404) background. I actually think that this makes more sense, since the authors claim that hif-1(et69) is a gain-of-function mutation that acts through suppression of ftn-2 expression. Thus, I would expect that without ftn-2 from the beginning, hif-1(et69) does not have an additional effect, and this seems to be what we see from the data. Thus, I would suggest that the authors reformulate their claims regarding the effect of hif1(et69) in the ftn-2(ok404) background, which seems to be absent (consistently with what one would expect).</p></disp-quote><p>We completely agree with the reviewer and indeed this is the meaning that we tried to convey all along. The text has now been modified as follows:</p><p>&quot;Lastly, <italic>ftn-2(et68)</italic> is still a potent <italic>fat-2(wa17)</italic> suppressor when hif-1 is knocked out (S2D Fig), suggesting that no other HIF-1-dependent functions are required as long as <italic>ftn-2</italic> is downregulated; this conclusion is supported by the observation that the potency of the ftn2(ok404) null allele to act as a <italic>fat-2(wa17)</italic> suppressor is not increased by including the <italic>hif-1(et69)</italic> allele (compare Fig 5H and S2E Fig).&quot;</p></body></sub-article></article>